UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act File Number: 811-04519
T. Rowe Price Capital Appreciation Fund, Inc.
(Exact name of registrant as specified in charter)
100 East Pratt Street, Baltimore, MD 21202
(Address of principal executive offices)
David Oestreicher
100 East Pratt Street, Baltimore, MD 21202
(Name and address of agent for service)
Registrant’s telephone number, including area code: (410) 345-2000
Date of fiscal year end: December 31
Date of reporting period: December 31, 2022
Item 1. Reports to Shareholders
(a) Report pursuant to Rule 30e-1
Highlights
and
Market
Commentary
Management’s
Discussion
of
Fund
Performance
Performance
and
Expenses
Financial
Highlights
Portfolio
of
Investments
Financial
Statements
and
Notes
Additional
Fund
Information
For
more
insights
from
T.
Rowe
Price
investment
professionals,
go
to
troweprice.com
.
T.
ROWE
PRICE
PRWCX
Capital
Appreciation
Fund
–
.
PACLX
Capital
Appreciation
Fund–
.
Advisor Class
TRAIX
Capital
Appreciation
Fund–
.
I Class
T.
ROWE
PRICE
Capital
Appreciation
Fund
HIGHLIGHTS
Markets
turned
sharply
lower
after
a
run
of
above-average
returns
in
recent
years.
Concerns
over
inflation,
aggressive
monetary
policy,
and
rising
fears
of
a
global
recession
drove
the
market
decline.
Your
fund
declined
by
11.9%
versus
the
S&P
500
Index’s
18.1%
loss
in
2022.
The
fund
continued
to
deliver
strong
long-term
risk-adjusted
returns,
generating
97%
of
the
S&P
500’s
return
while
taking
just
70%
of
the
index’s
risk
over
the
last
five
years.
We
are
more
optimistic
coming
into
2023
than
we
were
coming
into
2022
as
sentiment
has
gone
from
euphoric
to
negative,
valuations
have
improved,
and
we
believe
inflation
should
come
down
through
2023
and
into
2024.
We
see
pockets
of
value
in
cyclical
and
“growth
at
a
reasonable
price”
stocks,
as
well
as
in
the
utilities
sector,
in
high-quality
high
yield
debt
and
loans,
and
in
select
large-cap
names
that
offer
improved
valuations
after
a
period
of
weakness.
Log
in
to
your
account
at
troweprice.com
for
more
information.
*
Certain
mutual
fund
accounts
that
are
assessed
an
annual
account
service
fee
can
also
save
money
by
switching
to
e-delivery.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Management’s
Discussion
of
Fund
Performance
Fellow
Shareholders
After
three
consecutive
years
of
above-average
stock
market
returns
in
which
the
S&P
500
essentially
doubled,
markets
fell
sharply
in
2022
with
an
18%
decline
in
the
S&P
500
and
a
13%
decline
in
the
Bloomberg
U.S.
Aggregate
Bond
Index.
So
what
happened?
Higher-than-expected
inflation
—Inflation
was
materially
higher
than
expected
for
two
main
reasons.
First,
the
largest
component
of
the
consumer
price
index,
owners’
equivalent
rent,
surprised
to
the
upside
and
will
likely
stay
elevated
through
2023
as
the
lagged
effect
of
a
spike
in
new
rent
levels
in
2020–2021
fully
works
its
way
through
to
existing
renters
in
2022–2023.
The
good
news
here
is
that
new
rent
levels
have
started
stabilizing,
and
additional
apartment
supply
should
hit
the
market
in
2024–2025.
But
we
still
need
another
year
plus
to
reprice
existing
tenants
to
new
market
levels
in
2023
and
early
2024.
Second,
goods
prices,
which
historically
have
been
deflationary,
spiked
in
2021
and
stayed
higher
than
expected
in
2022
as
supply
chain
disruptions
took
longer
to
fix.
Again,
the
good
news
is
that
goods
prices,
especially
for
used
cars,
are
moving
in
the
right
direction
and
should
be
deflationary
in
2023
as
supply
chain
issues
and
labor
shortages
continue
to
improve.
Fed
raises
rates
aggressively
—Coming
into
2022,
the
Fed
funds
rate
was
set
at
0%
to
0.25%,
which
did
not
make
any
sense
given
that
inflation
had
been
rising
in
the
second
half
of
2021
and
the
economy
was
reasonably
strong.
There
was
no
logical
reason
rates
should
have
been
that
low
coming
into
2022.
However,
the
Federal
Reserve
recognized
its
mistake
and
through
2022
raised
rates
all
the
way
to
4.25%
to
4.50%.
This
was
one
of
the
most
aggressive
one-year
hiking
cycles
in
the
history
of
the
Federal
Reserve.
In
addition,
Fed
officials
have
been
very
vocal
about
continuing
to
raise
rates
and
keep
short-term
rates
high
in
order
to
bring
down
near-term
inflation.
The
massive
increase
in
short-term
rates
put
downward
pressure
on
bond
prices
and
was
the
principal
reason
for
the
13%
decline
in
the
Bloomberg
U.S.
Aggregate
Bond
Index.
Increased
fear
of
recession
—The
aggressive
rate
hikes
by
the
Federal
Reserve
were
intended
to
slow
down
the
economy
and
reduce
inflation.
These
short-term
interest
rate
hikes
caused
the
yield
curve
(the
difference
between
three-month
Treasury
bills
and
10-year
Treasury
bonds)
to
T.
ROWE
PRICE
Capital
Appreciation
Fund
invert—and
inverted
yield
curves
have
historically
preceded
recessions.
We
essentially
went
from
a
period
in
late
2021
when
no
one
was
calling
for
a
recession
to
a
period
in
which
it
seems
every
economic
soothsayer,
market
strategist,
and
high-profile
CEO
was
engaging
in
a
public
market
duel
to
see
who
could
be
the
most
bearish
on
the
economy.
While
the
risk
of
a
recession
is
clearly
elevated
today,
it
is
not
a
certainty.
And
even
if
there
is
a
recession,
we
believe
it
will
likely
be
mild
for
a
couple
of
reasons.
First,
some
of
the
most
cyclical
parts
of
the
economy,
such
as
automotive
production
and
commercial
aerospace
production,
are
already
at
recessionary
levels
and
are
far
more
likely
to
increase
in
2023
than
decline.
Second,
capital
spending,
historically
the
most
volatile
part
of
gross
domestic
product
(GDP),
is
likely
to
hang
in
better
in
2023
than
in
prior
downturns
simply
because
the
returns
on
capital
investment
to
address
supply
chain
challenges
and
augment
or
replace
high-cost
labor
are
quite
high
today.
In
addition,
incremental
capital
spending
from
reshoring
and
some
of
the
provisions
of
the
Inflation
Reduction
Act
should
be
supportive
in
2023
and
beyond.
Speculative
excess
coming
out
of
the
market
—There
were
multiple
bubbles
that
formed
in
2020–2021.
There
was
a
crypto
bubble
that
valued
various
coins
at
increasingly
higher
valuations
and
collapsed
in
2022,
culminating
in
the
bankruptcy
and
fraud
at
FTX.
There
was
a
special
purpose
acquisition
company
(SPAC)
bubble
in
which
investors
handed
over
billions
of
dollars
in
new
SPAC
IPOs
despite
the
fact
that
investors
and
even
the
owners
of
the
SPACs
themselves
did
not
know
what
businesses
they
would
eventually
buy
with
the
proceeds.
The
valuations
for
parts
of
the
tech
industry
and
private
companies
were
elevated
throughout
2021,
with
the
poster
child
probably
being
Tesla
(which
is
still
just
a
car
company)
trading
at
a
valuation
of
more
than
$1
trillion.
This
market
capitalization
represented,
at
its
peak,
more
than
two
times
the
value
of
every
publicly
traded
automotive
company
on
the
planet.
Some
of
the
air
coming
out
of
this
bubble
is
related
to
higher
interest
rates
putting
downward
pressure
for
the
highest-valued
companies
in
the
market,
but
maybe
more
importantly,
fundamentals
weakened.
What
is
striking
to
me
is
that
many
of
these
companies’
stock
prices
have
now
fallen
60%
to
80%
from
their
peaks
and
yet,
even
after
all
that
carnage,
we
struggle
to
find
attractive
investment
ideas
within
this
group
as
economic
valuations
(adding
in
stock
comp)
still
seem
high
relative
to
what
we
think
is
a
realistic
growth
rate
for
the
next
five
to
10
years.
Mega-cap
tech
weakness
—This
is
the
area
that
probably
surprised
us
the
most
in
2022.
Valuations
on
most
of
these
companies
coming
into
2022
seemed
reasonable
on
most
metrics.
All
of
these
companies
(Amazon,
Microsoft,
Salesforce,
Meta,
Apple,
Alphabet)
started
experiencing
a
T.
ROWE
PRICE
Capital
Appreciation
Fund
slowdown
in
their
revenue
growth
sometime
in
2022
from
a
combination
of
tough
comparisons
and
a
slowing
economy,
as
well
as
foreign
exchange
pressures.
These
stocks
probably
would
have
underperformed
simply
because
they
are
higher
beta
and
traded
at
a
premium
to
the
market.
However,
what
really
exacerbated
the
losses
with
Meta,
Alphabet,
and
Amazon
was
the
weakness
of
their
margins,
as
these
companies
spent
aggressively
on
hiring
and
new
business
initiatives.
Amazon
is
the
poster
child
for
this
as
we
expect
it
will
likely
post
lower
operating
profit
in
2023
than
2019,
despite
adding
$30
billion
in
earnings
before
interest
and
taxes
(EBIT)
from
advertising
and
Amazon
Web
Services
over
this
time
period.
This
implies
that
the
core
retail
business
and
new
business
initiatives
are
now
losing
tens
of
billions
of
dollars.
These
mega-cap
companies
are
all
large
parts
of
the
S&P
500,
and
their
weakness
put
further
downward
pressure
on
the
market.
The
good
news
here
is
that
these
companies
have
started
to
show
signs
of
discipline
on
expenses.
And
with
materially
easier
topline
comparisons
in
the
second
half
of
2023—including
foreign
exchange
going
from
a
headwind
to
a
tailwind—the
setup
for
these
stocks
looks
to
us
to
be
significantly
better
over
the
next
12
to
24
months
than
the
last.
So,
in
our
view,
those
five
factors
are
the
most
important
reasons
2022
was
a
very
disappointing
year
for
investors.
While
we
will
discuss
this
in
more
detail
in
the
outlook
section,
we
are
more
optimistic
coming
into
2023
than
we
were
heading
into
2022
as
sentiment
has
gone
from
euphoric
to
negative,
valuations
have
come
down,
and
we
think
inflation
should
come
down
throughout
2023
and
into
2024.
Having
said
all
of
that,
we
are
not
macro
investors.
We
have
found
that
we
created
the
greatest
alpha
over
time
for
clients
by
focusing
on
finding
attractively
valued
stocks,
bonds,
and
loans
and
by
focusing
on
exploiting
multiple
durable
market
inefficiencies.
This
is
where
we
believe
we
have
a
PERFORMANCE
COMPARISON
Total
Return
Periods
Ended
12/31/22
6
Months
12
Months
Capital
Appreciation
Fund
–
.
2.77%
-11.94%
Capital
Appreciation
Fund–
.
Advisor Class
2.62
-12.18
Capital
Appreciation
Fund–
.
I Class
2.81
-11.84
S&P
500
Index
2.31
-18.11
Lipper
Mixed-Asset
Target
Allocation
Growth
Funds
Index
1.22
-15.88
Morningstar
Allocation
–
50%
to
70%
Equity
Category
Average
1.07
-13.84
T.
ROWE
PRICE
Capital
Appreciation
Fund
competitive
edge.
We
have
found
that
this
strategy
is
far
superior
to
trying
to
speculate
on
Fed
policy,
GDP
levels,
growth
versus
value,
or
short-term
stock
market
movements—areas
where
we
don’t
have
an
edge
or
a
structural
market
inefficiency
to
exploit.
Before
we
discuss
fund
performance,
I
would
like
to
review
the
three
goals
of
the
Capital
Appreciation
Fund:
(1)
Generate
strong
risk-adjusted
returns
annually
(2)
Preserve
shareholder
capital
over
the
intermediate
term
(i.e.,
three
years)
(3)
Generate
equity-like
returns
with
less
risk
than
that
of
the
overall
market
over
a
full
market
cycle
(i.e.,
normally
five
years)
While
we
were
able
to
outperform
our
peers
and
beat
the
S&P
500
on
a
risk-
adjusted
basis,
our
fund
still
generated
a
negative
return
in
2022.
This
is
only
the
third
time
that
the
Capital
Appreciation
Fund
has
generated
a
negative
calendar
year
return
since
its
inception
back
in
1986.
While
we
are
unable
to
generate
positive
returns
in
every
market
environment,
especially
one
in
which
the
equity
and
fixed
income
markets
are
both
negative,
we
aim
to
keep
negative
return
years
to
a
minimum
by
focusing
on
high
risk-adjusted-return
asset
classes,
focusing
on
the
downside
risk
inherent
in
all
investments
just
as
much
as
on
the
upside,
and
continuing
to
take
advantage
of
market
and
security-
specific
dislocations
that
can
create
alpha
in
the
short
and
long
term.
For
the
year,
your
fund
declined
11.94%
as
compared
with
the
S&P
500’s
18.11%
decline.
(The
performance
of
the
Advisor
and
I
Class
shares
will
vary
due
to
different
fee
structures.)
Your
fund
outperformed
the
market
on
a
risk-adjusted
basis
over
this
period.
We
captured
66%
of
the
S&P
500’s
return
while
taking
on
only
71%
of
the
market’s
risk.
We
arrive
at
this
risk
number
by
comparing
the
standard
deviation
of
the
S&P
500
(24.08)
with
that
of
the
fund
(17.06)
for
the
12-month
period.
Standard
deviation
indicates
the
volatility
of
a
portfolio’s
total
return
as
measured
against
its
mean
performance.
In
general,
the
higher
the
standard
deviation,
the
greater
the
risk.
Using
a
more
academic
measure
of
the
fund’s
risk-adjusted
return,
your
fund
produced
a
Sharpe
ratio
of
-0.79
versus
-0.81
for
the
S&P
500.
The
Sharpe
ratio
measures
a
portfolio's
return
above
the
risk-free
Treasury
rate
(excess
return),
divided
by
the
amount
of
risk
taken
(measured
by
standard
deviation).
The
larger
the
Sharpe
ratio,
the
better
the
portfolio's
risk-adjusted
return.
T.
ROWE
PRICE
Capital
Appreciation
Fund
While
technically
we
outperformed
the
S&P
500
on
a
Sharpe
ratio
basis
in
2022,
we
do
not
believe
the
Sharpe
ratio
is
a
great
measure
of
risk-adjusted
returns
when
returns
are
negative.
There
are
academic
papers
that
debate
how
to
interpret
Sharpe
ratios
in
periods
with
negative
returns,
as
well
as
how
the
ratio
might
be
modified
during
such
periods
to
provide
more
insight.
But
the
bottom
line,
in
our
view,
is
that
while
we
technically
outperformed
on
a
Sharpe
ratio
basis,
this
metric
is
basically
irrelevant
during
periods
of
negative
returns.
What
matters
more
is
absolute
returns
–
and
we
feel
good
we
beat
our
peers
and
the
S&P
500
in
a
very
difficult
environment.
As
for
our
second
goal—capital
preservation
over
the
intermediate
term—your
fund
generated
a
23.33%
cumulative
return
over
the
last
three
years.
As
for
our
final
goal—equity-like
returns
with
less
risk
than
the
market
over
a
full
market
cycle—your
fund
generated
a
54.63%
cumulative
return
over
the
last
five
years
versus
56.88%
for
the
S&P
500.
Based
on
annualized
returns
of
9.11%
for
your
fund
versus
9.42%
for
the
S&P
500,
your
fund
generated
97%
of
the
market’s
return
over
the
last
five
years
while
taking
on
70%
of
the
market’s
risk.
However,
since
the
current
portfolio
management
team
took
over
the
management
of
the
fund
in
June
of
2006,
the
fund
outperformed
the
S&P
500
by
delivering
101%
of
the
S&P
500’s
return
while
taking
only
69%
of
the
market’s
risk.
In
addition,
our
equities
outperformed
the
S&P
500
by
167
basis
points
(-16.44%
versus
-18.11%)
in
2022.
Over
the
last
3-,
5-,
and
10-year
periods,
our
equities
outperformed
the
S&P
500
by
an
average
of
267,
368,
and
405
basis
points
annualized,
respectively.
While
our
equities
have
substantially
outperformed
the
market,
our
equities
have
also
been
less
risky
(from
a
beta
perspective)
than
the
market.
Our
fixed
income
investments
outperformed
the
Bloomberg
U.S.
Aggregate
Bond
Index
by
1,050
basis
points
(-2.51%
versus
-13.01)
in
2022
as
we
entered
the
year
with
a
record-low
fixed
income
duration
portfolio
with
no
Treasuries
and
almost
70%
of
the
fixed
income
portfolio
in
floating
rate
loans.
The
floating
rate
loan
index
was
down
less
than
1%,
and,
in
aggregate,
our
loans
generated
positive
returns.
For
the
1-,
3-,
5-,
and
10-year
periods
ended
December
31,
2022,
we
outperformed
our
Lipper
and
Morningstar
peers
over
every
period,
and
in
2022,
we
were
ranked
in
the
26
th
percentile
in
Morningstar
and
14
th
percentile
in
Lipper.
Over
the
3-,
5-
and
10-year
periods,
we
were
in
the
third
percentile
or
better
for
both
peer
groupings.
(Based
on
cumulative
total
return,
the
Capital
Appreciation
Fund
ranked
65
of
468,
6
of
434,
2
of
417,
and
2
of
338
funds
in
the
Lipper
mixed-asset
target
allocation
growth
funds
universe
for
the
1-,
3-,
5-,
and
10-year
periods
ended
December
31,
2022,
respectively.
Based
on
average
annual
total
return,
the
Capital
Appreciation
Fund
ranked
170
of
761,
T.
ROWE
PRICE
Capital
Appreciation
Fund
12
of
720,
4
of
697,
and
3
of
612
fund
in
the
Morningstar
Allocation
50%
to
70%
Equity
category
for
the
1-,
3-,
5-,
and
10-year
periods
ended
December
31,
2022,
respectively.
Results
may
vary
for
other
periods.
Past
performance
cannot
guarantee
future
results.
)
As
a
general
rule,
we
focus
much
more
on
trying
to
outperform
the
Morningstar
category
simply
because
the
equity
and
fixed
income
weights
in
this
index
are
much
more
similar
to
the
Capital
Appreciation
Fund’s
long-term
equity
and
fixed
income
weights.
The
Lipper
peers
have
a
larger
structural
allocation
to
equities,
and
in
a
year
like
2022,
when
equity
markets
are
down
materially,
this
structurally
higher
overweight
in
Lipper
artificially
makes
the
Capital
Appreciation
Fund’s
performance
look
better
than
it
really
was.
However,
let
us
reiterate
that
we
do
not
manage
your
fund
to
beat
these
benchmarks.
The
Capital
Appreciation
Fund
has
different
objectives
than
most
of
its
benchmark
peers.
It
is
a
unique
fund
with
a
clear
focus
on
strong
risk-
adjusted
returns,
intermediate-term
capital
preservation,
and
long-term
capital
appreciation
that
does
not
fit
neatly
into
any
current
benchmark.
Within
our
equity
sleeve,
the
consumer
discretionary
sector
was
our
largest
contributor
to
relative
returns.
Almost
all
of
this
alpha
was
a
function
of
our
large
investment
in
Yum!
Brands.
While
Yum!
Brands
faced
headwinds
in
2022
from
a
higher
tax
rate,
the
loss
of
income
from
Russian
franchisees
(Yum
exited
the
Russian
market
following
the
invasion
of
Ukraine),
weak
Chinese
sales
due
to
lockdowns,
and
a
weak
dollar,
the
stock
was
down
only
6%
last
year
and
was
one
of
our
largest
holdings.
The
magic
of
the
Yum
business
is
that
its
restaurants
are
98%
franchised,
its
quick-service
business
is
economically
AVERAGE
ANNUAL
PERFORMANCE
COMPARISON
Periods
Ended
12/31/22
1
Year
3
Years
5
Years
10
Years
Capital
Appreciation
Fund
–
.
-11.94%
7.24%
9.11%
10.83%
S&P
500
Index
-18.11
7.66
9.42
12.56
Lipper
Mixed-Asset
Target
Allocation
Growth
Funds
Index
-15.88
4.11
5.11
7.51
Morningstar
Allocation
–
50%
to
70%
Equity
Category
Average
-13.84
3.03
4.13
6.01
The
fund’s
expense
ratio
was
0.70%
as
of
its
fiscal
year
ended
December
31,
2021.
Current
performance
may
be
higher
or
lower
than
the
quoted
past
performance,
which
cannot
guarantee
future
results.
Share
price,
principal
value,
and
return
will
vary,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
For
the
most
recent
month-end
performance
information,
please
visit
our
website
at
troweprice.com
or
call
1-800-225-5132.
T.
ROWE
PRICE
Capital
Appreciation
Fund
resilient
and,
in
a
higher
inflation
environment,
its
franchisees
pass
through
this
higher
inflation
to
customers,
which
then
drives
higher
royalty
revenues
to
Yum!
Brands.
The
company
is
run
by
an
exceptional
management
team
that
is
accelerating
new-store
growth,
innovating
more
than
its
peers,
generating
strong
free
cash
flow,
and
returning
excess
cash
to
shareholders.
Our
position
size
in
Yum
came
down
in
late
2022
due
to
the
stock’s
outperformance,
but
it
remains
one
of
our
largest
positions
in
the
fund.
(Please
refer
to
the
fund’s
portfolio
of
investments
for
a
complete
list
of
holdings
and
the
amount
each
represents
in
the
portfolio.)
Information
technology
was
our
second-largest
contributor
to
relative
performance.
Coming
into
2022,
information
technology
was
our
largest
sector
underweight
as
we
felt
valuations
were
elevated.
However,
as
this
sector
fell
sharply
over
the
course
of
2022,
we
added
exposure
and
exited
the
year
with
an
overweight.
Unlike
in
consumer
discretionary,
where
Yum!
Brands
was
solely
responsible
for
our
alpha
generation,
in
information
technology,
there
were
several
contributors.
NXP
Semiconductors
and
Texas
Instruments
were
new
holdings
in
2022,
and
we
bought
both
after
they
were
down
substantially
from
their
late-2021
highs.
We
are
big
believers
that
semiconductor
content
will
continue
to
grow
in
the
high
single
digits
as
electric
and
autonomous
vehicles
continue
to
expand
and
as
industrial
users
add
more
semiconductors
to
gain
data
insights,
drive
better
power
efficiency,
and
enable
more
digital
interfaces.
Both
of
these
companies
have
around
70%
of
their
business
tied
to
the
automotive
and
industrial
end
markets,
have
exceptional
management
teams,
generate
strong
free
cash
flow,
and
return
excess
cash
to
shareholders.
SECTOR
DIVERSIFICATION
Percent
of
Net
Assets
6/30/22
12/31/22
Information
Technology
20.1%
17.1%
Health
Care
15.2
14.6
Industrials
and
Business
Services
11.1
10.5
Financials
7.6
6.8
Consumer
Discretionary
7.3
5.1
Utilities
1.4
3.2
Communication
Services
3.4
2.0
Energy
0.5
1.6
Materials
0.3
1.0
Consumer
Staples
0.7
0.3
Real
Estate
0.0
0.0
Other
and
Reserves
32.4
37.8
Total
100.0%
100.0%
Historical
weightings
reflect
current
industry/sector
classifications.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Your
fund
has
employed
a
covered
call
overwriting
strategy
consistently
since
2008.
This
involves
buying
an
equity
security
and
writing
a
call
option
that
becomes
exercisable
at
a
higher
price
in
return
for
an
upfront
premium.
In
2022,
our
covered
call
program
had
a
positive
impact
on
your
fund’s
performance.
The
energy
sector
was
our
worst-performing
sector
on
a
relative
basis
as
the
sector
was
up
66%
in
2022
and
outperformed
the
S&P
500
by
8,400
basis
points.
The
magnitude
of
outperformance
was
somewhat
surprising
as
the
various
oil
prices
(WTI
and
Brent)
were
up
only
7%
to
11%
for
the
year.
However,
the
energy
sector
really
benefited
as
portfolio
managers
bought
the
sector
as
a
way
to
play
higher
inflation.
The
sector
also
benefited
from
geopolitical
instability
associated
with
Russia’s
invasion
of
Ukraine.
While
we
remain
underweight
energy,
we
do
have
exposure
to
what
we
believe
are
the
three
best
companies
in
the
space:
EOG,
Pioneer,
and
ConocoPhillips.
EOG
is
very
good
at
capital
allocation
and
is
a
best-in-class
explorer
of
new
shale
plays
in
the
United
States.
Pioneer
has
the
best
acreage
in
the
heart
of
the
Permian
Basin
and
is
a
takeover
candidate.
ConocoPhillips
has
exceptional
management,
good
capital
allocation,
and
a
well-diversified
portfolio.
Portfolio
Outlook
After
coming
into
2022
cautious
on
markets
and
underweight
stocks
due
to
elevated
valuations,
slowing
earnings
growth,
and
likely
slowing
economic
growth,
we
feel
better
about
2023.
The
S&P
500
fell
18%
last
year,
yet
when
all
is
said
and
done,
earnings
are
likely
to
have
grown
5%
to
6%.
The
combination
of
a
lower
S&P
500
level
and
higher
earnings
means
the
valuation
of
the
market
has
come
down
from
21x
forward
earnings
to
16x
to
17x.
While
investors
are
very
worried
about
a
recession
and
elevated
inflation,
we
believe
inflation
will
continue
to
come
down.
And
even
if
there
is
a
recession,
we
believe
it
will
be
mild.
Regardless
of
how
the
macro
environment
plays
out,
we
will
work
hard
and
endeavor
to
find
a
way
to
outperform,
to
generate
strong
risk-adjusted
returns,
and
to
minimize
downside
risk.
Where
do
we
see
value?
Cyclical
stocks—Many,
but
not
all,
cyclicals
are
already
partially
or
completely
pricing
in
a
recession.
While
this
does
not
mean
they
cannot
go
down
further,
it
does
mean
a
lot
of
bad
news
is
already
priced
in
and
risk/
reward
is
promising.
Banks
and
semiconductor
stocks
look
particularly
compelling
here.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Growth
at
a
reasonable
price
(GARP)
stocks—While
GARP
outperformed
last
year,
we
believe
that
over
the
long
term,
GARP
stocks
still
offer
the
best
risk-adjusted
returns
in
the
market.
And
not
all
GARP
stocks
outperformed
last
year;
life
sciences
tools,
exchanges,
and
credit
bureau
spaces
all
look
very
attractive.
Utilities
over
staples—
While
both
sectors
were
flat
to
up
slightly
last
year,
staples
continue
to
trade
at
a
large
premium
to
utilities—despite
the
fact
that
utilities
should
grow
faster
and
have
higher
dividend
yields—and
also
tend
to
have
less
downside
risk,
less
secular
risk,
and
less
foreign
exchange
and
commodity
risk.
High-quality
high
yield
and
loans—We
continue
to
think
high-quality
high
yield
bonds
and
loans
that
currently
yield
7%
to
8%
offer
compelling
risk-
adjusted
returns
relative
to
the
equity
market.
Select
large-cap
tech—As
we
noted
earlier,
we
believe
the
tactical
setup
for
large-cap
tech
stocks
has
improved
versus
12
months
ago
as
valuations
have
come
down
and
investors
have
gone
from
being
overweight
these
stocks
to
universally
underweight.
In
the
second
half
of
2023
or
possibly
early
2024,
we
expect
that
growth
rates
will
stabilize—if
not
improve—and,
maybe
most
importantly,
margins
and
profits
will
start
to
improve.
Where
do
we
not
see
value?
Where
everyone
is
hiding
out—Where
investors
are
seeking
safety
and
where
valuations
are
expensive.
The
most
obvious
areas
are
defense,
energy,
staples,
agriculture,
and
pharmaceuticals.
While
we
have
modest
exposure
to
these
sectors,
we
continue
to
be
massively
underweight.
Speculative
and
profitless
tech—As
mentioned
before,
on
an
economic
basis,
we
still
don’t
see
valuations
as
compelling
given
the
likely
growth
trajectory
from
here.
SECURITY
DIVERSIFICATION
Capital
Appreciation
Fund
T.
ROWE
PRICE
Capital
Appreciation
Fund
IN
CLOSING
We
would
like
to
thank
all
the
analysts,
associate
analysts,
quantitative
analysts,
and
members
of
our
team
(Mike
Signore,
Chen
Tian,
Nikhil
Shah,
Vivek
Rajeswaran,
Jared
Duda,
and
Brian
Solomon)
for
their
assistance
in
2022.
At
the
end
of
2022,
we
announced
promotions
and
new
responsibilities
for
three
team
members.
Vivek
Rajeswaran
and
Mike
Signore
have
become
associate
portfolio
managers
of
the
Capital
Appreciation
Strategy.
In
addition,
Brian
Solomon
will
become
the
team
lead
on
fixed
income
analysis
and
work
with
me
on
managing
the
fixed
income
sleeve
of
the
portfolio
and
working
with
our
high
yield
analysts.
The
Capital
Appreciation
team
is
as
strong
and
deep
as
we
have
ever
been.
Respectfully
submitted,
David
R.
Giroux
Chairman
of
the
fund’s
Investment
Advisory
Committee
January
22,
2023
The
committee
chairman
has
day-to-day
responsibility
for
managing
the
portfolio
and
works
with
committee
members
in
developing
and
executing
the
fund’s
investment
program.
The
views
expressed
reflect
the
opinions
of
T.
Rowe
Price
as
of
the
date
of
this
report
and
are
subject
to
change
based
on
changes
in
market,
economic,
or
other
conditions.
These
views
are
not
intended
to
be
a
forecast
of
future
events
and
are
no
guarantee
of
future
results.
T.
ROWE
PRICE
Capital
Appreciation
Fund
RISKS
OF
INVESTING
As
with
all
stock
and
bond
mutual
funds,
the
fund’s
share
price
can
fall
because
of
weakness
in
the
stock
or
bond
markets,
a
particular
industry,
or
specific
holdings.
Stock
markets
can
decline
for
many
reasons,
including
adverse
political
or
economic
developments,
changes
in
investor
psychology,
or
heavy
institutional
selling.
The
prospects
for
an
industry
or
company
may
deteriorate
because
of
a
variety
of
factors,
including
disappointing
earnings
or
changes
in
the
competitive
environment.
In
addition,
the
investment
manager’s
assessment
of
companies
held
in
a
fund
may
prove
incorrect,
resulting
in
losses
or
poor
performance
even
in
rising
markets.
A
sizable
cash
or
fixed
income
position
may
hinder
the
fund
from
participating
fully
in
a
strong,
rapidly
rising
bull
market.
In
addition,
significant
exposure
to
bonds
increases
the
risk
that
the
fund’s
share
value
could
be
hurt
by
rising
interest
rates
or
credit
downgrades
or
defaults.
Convertible
securities
are
also
exposed
to
price
fluctuations
of
the
company’s
stock.
GLOSSARY
Lipper
indexes:
Fund
benchmarks
that
consist
of
a
small
number
of
the
largest
mutual
funds
in
a
particular
category
as
tracked
by
Lipper
Inc.
Morningstar
allocation–50%
to
70%
equity
category
average:
Tracks
the
performance
of
funds
that
seek
capital
appreciation
and
income
by
investing
in
multiple
asset
classes,
including
stocks,
bonds,
and
cash.
Equity
exposures
range
from
50%
to
70%.
BENCHMARK
INFORMATION
Note:
Bloomberg
®
and the
Bloomberg
U.S.
Aggregate
Bond
Index
are
service
marks
of
Bloomberg
Finance
L.P.
and
its
affiliates,
including
Bloomberg
Index
Services
Limited
(“BISL”),
the
administrator
of
the
index
(collectively,
“Bloomberg”)
and
have
been
licensed
for
use
for
certain
purposes
by
T.
Rowe
Price.
Bloomberg
is
not
affiliated
with
T.
Rowe
Price,
and
Bloomberg
does
not
approve,
endorse,
review,
or
recommend
its
products.
Bloomberg
does
not
guarantee
the
timeliness,
accurateness,
or
completeness
of
any
data
or
information
relating
to
its
products.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Note:
Portions
of
the
mutual
fund
information
contained
in
this
report
was
supplied
by
Lipper,
a
Refinitiv
Company,
subject
to
the
following:
Copyright
2023
©
Refinitiv.
All
rights
reserved.
Any
copying,
republication
or
redistribution
of
Lipper
content
is
expressly
prohibited
without
the
prior
written
consent
of
Lipper.
Lipper
shall
not
be
liable
for
any
errors
or
delays
in
the
content,
or
for
any
actions
taken
in
reliance
thereon.
Note:
©2023
Morningstar,
Inc.
All
rights
reserved.
The
information
contained
therein:
(1)
is
proprietary
to
Morningstar
and/or
its
content
providers;
(2)
may
not
be
copied
or
distributed;
and
(3)
is
not
warranted
to
be
accurate,
complete,
or
timely.
Neither
Morningstar
nor
its
content
providers
are
responsible
for
any
damages
or
losses
arising
from
any
use
of
this
information.
Past
performance
is
no
guarantee
of
future
results.
Note:
The
S&P
500
Index
is
a
product
of
S&P
Dow
Jones
Indices
LLC,
a
division
of
S&P
Global,
or
its
affiliates
(“SPDJI”)
and
has
been
licensed
for
use
by
T.
Rowe
Price.
Standard
& Poor’s
®
and
S&P
®
are
registered
trademarks of
Standard
&
Poor’s
Financial
Services
LLC,
a
division
of
S&P
Global (“S&P”);
Dow
Jones
®
is
a
registered
trademark
of
Dow
Jones
Trademark
Holdings
LLC
(“Dow
Jones”);
T.
Rowe
Price
is
not
sponsored,
endorsed,
sold
or
promoted
by
SPDJI,
Dow
Jones,
S&P,
or
their
respective
affiliates,
and
none
of
such
parties
make
any
representation
regarding
the
advisability
of
investing
in
such
product(s)
nor
do
they
have
any
liability
for
any
errors,
omissions,
or
interruptions
of
the
S&P
500
Index.
T.
ROWE
PRICE
Capital
Appreciation
Fund
PORTFOLIO
HIGHLIGHTS
TWENTY-FIVE
LARGEST
HOLDINGS
Percent
of
Net
Assets
12/31/22
U.S.
Treasury
Notes
9.1%
Microsoft
5.2
HUB
International
3.6
PNC
Financial
Services
Group
2.9
Yum!
Brands
2.5
Apple
2.4
Amazon.com
2.1
GE
2.0
Intercontinental
Exchange
2.0
UnitedHealth
Group
2.0
Fortive
2.0
Thermo
Fisher
Scientific
1.9
PerkinElmer
1.8
NXP
Semiconductors
1.8
Danaher
1.6
Ingersoll-Rand
1.6
TE
Connectivity
1.5
Ameren
1.5
Alphabet
1.4
Texas
Instruments
1.4
UKG
1.4
Equifax
1.3
Waste
Connections
1.3
Becton,
Dickinson
&
Company
1.3
TransUnion
1.3
Total
56.9%
Note:
The
information
shown
does
not
reflect
any
exchange-traded
funds
(ETFs),
cash
reserves,
or
collateral
for
securities
lending
that
may
be
held
in
the
portfolio.
T.
ROWE
PRICE
Capital
Appreciation
Fund
PORTFOLIO
HIGHLIGHTS
MAJOR
PORTFOLIO
CHANGES
Listed
in
descending
order
of
size.
Six
Months
Ended
12/31/2022
Largest
Purchases
Largest
Sales
*Position
added.
T.
ROWE
PRICE
Capital
Appreciation
Fund
GROWTH
OF
$10,000
This
chart
shows
the
value
of
a
hypothetical
$10,000
investment
in
the
fund
over
the
past
10
fiscal
year
periods
or
since
inception
(for funds
lacking
10-year
records).
The
result
is
compared
with
benchmarks,
which
include
a
broad-based
market
index
and
may
also
include
a
peer
group
average
or
index.
Market
indexes
do
not
include
expenses,
which
are
deducted
from
fund
returns
as
well
as
mutual fund
averages
and
indexes.
CAPITAL
APPRECIATION
FUND
Note:
Performance
for
the
Advisor
and
I Class
shares
will
vary
due
to
their
differing
fee
structures.
See
the
Average
Annual
Compound
Total
Return
table.
T.
ROWE
PRICE
Capital
Appreciation
Fund
AVERAGE
ANNUAL
COMPOUND
TOTAL
RETURN
Periods
Ended
12/31/22
1
Year
5
Years
10
Years
Since
Inception
Inception
Date
Capital
Appreciation
Fund
–
.
-11.94%
9.11%
10.83%
–
–
Capital
Appreciation
Fund–
.
Advisor Class
-12.18
8.80
10.51
–
–
Capital
Appreciation
Fund–
.
I Class
-11.84
9.23
–
9.99%
12/17/15
The
fund’s
performance
information
represents
only
past
performance
and
is
not
necessarily
an
indication
of
future
results.
Current
performance
may
be
lower
or
higher
than
the
performance
data
cited.
Share
price,
principal
value,
and
return
will
vary,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
For
the
most
recent
month-end
performance,
please
visit
our
website
(troweprice.com)
or
contact
a
T.
Rowe
Price
representative
at
1
-
800
-
225
-
5132
or,
for
0.02
Advisor
and
0.03
I
Class
shares,
1-800-638-8790.
This
table
shows
how
the
fund
would
have
performed
each
year
if
its
actual
(or
cumulative)
returns
had
been
earned
at
a
constant
rate.
Average
annual
total
return
figures
include
changes
in
principal
value,
reinvested
dividends,
and
capital
gain
distributions.
Returns
do
not
reflect
taxes
that
the
shareholder
may
pay
on
fund
distributions
or
the
redemption
of
fund
shares.
When
assessing
performance,
investors
should
consider
both
short-
and
long-term
returns.
T.
ROWE
PRICE
Capital
Appreciation
Fund
EXPENSE
RATIO
FUND
EXPENSE
EXAMPLE
As
a
mutual
fund
shareholder,
you
may
incur
two
types
of
costs:
(1)
transaction
costs,
such
as
redemption
fees
or
sales
loads,
and
(2)
ongoing
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
fund
expenses.
The
following
example
is
intended
to
help
you
understand
your
ongoing
costs
(in
dollars)
of
investing
in
the
fund
and
to
compare
these
costs
with
the
ongoing
costs
of
investing
in
other
mutual
funds.
The
example
is
based
on
an
investment
of
$1,000
invested
at
the
beginning
of
the
most
recent
six-month
period
and
held
for
the
entire
period.
Please
note
that
the
fund
has
three
share
classes:
The
original
share
class
(Investor
Class)
charges
no
distribution
and
service
(12b-1)
fee,
the
Advisor
Class
shares
are
offered
only
through
unaffiliated
brokers
and
other
financial
intermediaries
and
charge
a
0.25%
12b-1
fee,
and
I
Class
shares
are
available
to
institutionally
oriented
clients
and
impose
no
12b-1
or
administrative
fee
payment.
Each
share
class
is
presented
separately
in
the
table.
Actual
Expenses
The
first
line
of
the
following
table
(Actual)
provides
information
about
actual
account
values
and
expenses
based
on
the
fund’s
actual
returns.
You
may
use
the
information
on
this
line,
together
with
your
account
balance,
to
estimate
the
expenses
that
you
paid
over
the
period.
Simply
divide
your
account
value
by
$1,000
(for
example,
an
$8,600
account
value
divided
by
$1,000
=
8.6),
then
multiply
the
result
by
the
number
on
the
first
line
under
the
heading
“Expenses
Paid
During
Period”
to
estimate
the
expenses
you
paid
on
your
account
during
this
period.
Hypothetical
Example
for
Comparison
Purposes
The
information
on
the
second
line
of
the
table
(Hypothetical)
is
based
on
hypothetical
account
values
and
expenses
derived
from
the
fund’s
actual
expense
ratio
and
an
assumed
5%
per
year
rate
of
return
before
expenses
(not
the
fund’s
actual
return).
You
may
compare
the
ongoing
costs
of
investing
in
the
fund
with
other
funds
by
contrasting
this
5%
hypothetical
example
and
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
the
other
funds.
The
hypothetical
account
values
and
expenses
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period.
Capital
Appreciation
Fund
0.70%
Capital
Appreciation
Fund–Advisor
Class
0.99
Capital
Appreciation
Fund–I
Class
0.59
The
expense
ratio
shown
is
as
of
the
fund’s
most
recent
prospectus.
This
number
may
vary
from
the
expense
ratio
shown
elsewhere
in
this
report
because
it
is
based
on
a
different
time
period
and,
if
applicable,
includes
acquired
fund
fees
and
expenses
but
does
not
include
fee
or
expense
waivers.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Note:
T.
Rowe
Price
charges
an
annual
account
service
fee
of
$20,
generally
for
accounts
with
less
than
$10,000.
The
fee
is
waived
for
any
investor
whose
T.
Rowe
Price
mutual
fund
accounts
total
$50,000
or
more;
accounts
electing
to
receive
electronic
delivery
of
account
statements,
transaction
confirmations,
prospectuses,
and
shareholder
reports;
or
accounts
of
an
investor
who
is
a
T.
Rowe
Price
Personal
Services
or
Enhanced
Personal
Services
client
(enrollment
in
these
programs
generally
requires
T.
Rowe
Price
assets
of
at
least
$250,000).
This
fee
is
not
included
in
the
accompanying
table.
If
you
are
subject
to
the
fee,
keep
it
in
mind
when
you
are
estimating
the
ongoing
expenses
of
investing
in
the
fund
and
when
comparing
the
expenses
of
this
fund
with
other
funds.
You
should
also
be
aware
that
the
expenses
shown
in
the
table
highlight
only
your
ongoing
costs
and
do
not
reflect
any
transaction
costs,
such
as
redemption
fees
or
sales
loads.
Therefore,
the
second
line
of
the
table
is
useful
in
comparing
ongoing
costs
only
and
will
not
help
you
determine
the
relative
total
costs
of
owning
different
funds.
To
the
extent
a
fund
charges
transaction
costs,
however,
the
total
cost
of
owning
that
fund
is
higher.
CAPITAL
APPRECIATION
FUND
Beginning
Account
Value
7/1/22
Ending
Account
Value
12/31/22
Expenses
Paid
During
Period*
7/1/22
to
12/31/22
Investor
Class
Actual
$1,000.00
$1,027.70
$3.63
Hypothetical
(assumes
5%
return
before
expenses)
1,000.00
1,021.63
3.62
Advisor
Class
Actual
1,000.00
1,026.20
4.95
Hypothetical
(assumes
5%
return
before
expenses)
1,000.00
1,020.32
4.94
I
Class
Actual
1,000.00
1,028.10
2.96
Hypothetical
(assumes
5%
return
before
expenses)
1,000.00
1,022.28
2.96
*
Expenses
are
equal
to
the
fund’s
annualized
expense
ratio
for
the
6-month
period,
multiplied
by
the
average
account
value
over
the
period,
multiplied
by
the
number
of
days
in
the
most
recent
fiscal
half
year
(184),
and
divided
by
the
days
in
the
year
(365)
to
reflect
the
half-year
period.
The
annualized
expense
ratio
of
the
1
Investor
Class
was
0.71%,
the
2
Advisor Class
was
0.97%,
and
the
3
I Class
was
0.58%.
FUND
EXPENSE
EXAMPLE
(CONTINUED)
T.
ROWE
PRICE
Capital
Appreciation
Fund
For
a
share
outstanding
throughout
each
period
Investor
Class
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
NET
ASSET
VALUE
Beginning
of
period
$
36
.96
$
34
.11
$
31
.22
$
26
.53
$
28
.28
Investment
activities
Net
investment
income
(1)(2)
0
.49
0
.35
0
.40
0
.49
0
.72
(3)
Net
realized
and
unrealized
gain/
loss
(
4
.91
)
5
.91
5
.21
6
.02
(
0
.49
)
Total
from
investment
activities
(
4
.42
)
6
.26
5
.61
6
.51
0
.23
Distributions
Net
investment
income
(
0
.47
)
(
0
.35
)
(
0
.40
)
(
0
.48
)
(
0
.67
)
Net
realized
gain
(
2
.34
)
(
3
.06
)
(
2
.32
)
(
1
.34
)
(
1
.31
)
Total
distributions
(
2
.81
)
(
3
.41
)
(
2
.72
)
(
1
.82
)
(
1
.98
)
NET
ASSET
VALUE
End
of
period
$
29
.73
$
36
.96
$
34
.11
$
31
.22
$
26
.53
T.
ROWE
PRICE
Capital
Appreciation
Fund
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Investor
Class
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
Ratios/Supplemental
Data
Total
return
(2)(4)
(
11
.94
)
%
18
.53
%
18
.16
%
24
.61
%
0
.62
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
(5)
0
.73
%
0
.70
%
0
.70
%
0
.70
%
0
.71
%
Net
expenses
after
waivers/
payments
by
Price
Associates
0
.71
%
0
.68
%
0
.69
%
0
.70
%
0
.71
%
Net
investment
income
1
.45
%
0
.95
%
1
.26
%
1
.61
%
2
.49
%
(3)
Portfolio
turnover
rate
83
.9
%
47
.8
%
87
.3
%
44
.8
%
65
.2
%
Net
assets,
end
of
period
(in
millions)
$26,104
$40,460
$35,253
$30,822
$24,535
0
%
0
%
0
%
0
%
0
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
7
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
Reflects
a
special
dividend
which
amounted
to
$0.29
per
share
and
1.00%
of
average
net
assets.
(4)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
(5)
See
Note
7
.
Prior
to
12/31/19,
the
gross
expense
ratios
presented
are
net
of
a
management
fee
waiver
in
effect
during
the
period,
as
applicable.
T.
ROWE
PRICE
Capital
Appreciation
Fund
For
a
share
outstanding
throughout
each
period
Advisor
Class
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
NET
ASSET
VALUE
Beginning
of
period
$
36
.49
$
33
.70
$
30
.88
$
26
.27
$
27
.99
Investment
activities
Net
investment
income
(1)(2)
0
.40
0
.24
0
.31
0
.40
0
.63
(3)
Net
realized
and
unrealized
gain/
loss
(
4
.85
)
5
.84
5
.13
5
.94
(
0
.47
)
Total
from
investment
activities
(
4
.45
)
6
.08
5
.44
6
.34
0
.16
Distributions
Net
investment
income
(
0
.40
)
(
0
.23
)
(
0
.30
)
(
0
.39
)
(
0
.57
)
Net
realized
gain
(
2
.34
)
(
3
.06
)
(
2
.32
)
(
1
.34
)
(
1
.31
)
Total
distributions
(
2
.74
)
(
3
.29
)
(
2
.62
)
(
1
.73
)
(
1
.88
)
NET
ASSET
VALUE
End
of
period
$
29
.30
$
36
.49
$
33
.70
$
30
.88
$
26
.27
T.
ROWE
PRICE
Capital
Appreciation
Fund
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Advisor
Class
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
Ratios/Supplemental
Data
Total
return
(2)(4)
(
12
.18
)
%
18
.22
%
17
.80
%
24
.20
%
0
.38
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
(5)
0
.99
%
0
.99
%
1
.00
%
0
.99
%
1
.00
%
Net
expenses
after
waivers/
payments
by
Price
Associates
0
.97
%
0
.97
%
0
.99
%
0
.99
%
1
.00
%
Net
investment
income
1
.22
%
0
.66
%
0
.97
%
1
.32
%
2
.20
%
(3)
Portfolio
turnover
rate
83
.9
%
47
.8
%
87
.3
%
44
.8
%
65
.2
%
Net
assets,
end
of
period
(in
millions)
$654
$795
$770
$866
$788
0
%
0
%
0
%
0
%
0
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
7
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
Reflects
a
special
dividend
which
amounted
to
$0.29
per
share
and
1.02%
of
average
net
assets.
(4)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
(5)
See
Note
7
.
Prior
to
12/31/19,
the
gross
expense
ratios
presented
are
net
of
a
management
fee
waiver
in
effect
during
the
period,
as
applicable.
T.
ROWE
PRICE
Capital
Appreciation
Fund
For
a
share
outstanding
throughout
each
period
I
Class
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
NET
ASSET
VALUE
Beginning
of
period
$
36
.99
$
34
.14
$
31
.24
$
26
.55
$
28
.29
Investment
activities
Net
investment
income
(1)(2)
0
.56
0
.40
0
.44
0
.52
0
.77
(3)
Net
realized
and
unrealized
gain/
loss
(
4
.95
)
5
.91
5
.22
6
.02
(
0
.50
)
Total
from
investment
activities
(
4
.39
)
6
.31
5
.66
6
.54
0
.27
Distributions
Net
investment
income
(
0
.54
)
(
0
.40
)
(
0
.44
)
(
0
.51
)
(
0
.70
)
Net
realized
gain
(
2
.34
)
(
3
.06
)
(
2
.32
)
(
1
.34
)
(
1
.31
)
Total
distributions
(
2
.88
)
(
3
.46
)
(
2
.76
)
(
1
.85
)
(
2
.01
)
NET
ASSET
VALUE
End
of
period
$
29
.72
$
36
.99
$
34
.14
$
31
.24
$
26
.55
T.
ROWE
PRICE
Capital
Appreciation
Fund
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
I
Class
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
Ratios/Supplemental
Data
Total
return
(2)(4)
(
11
.84
)
%
18
.67
%
18
.31
%
24
.70
%
0
.76
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
(5)
0
.60
%
0
.59
%
0
.59
%
0
.60
%
0
.59
%
Net
expenses
after
waivers/
payments
by
Price
Associates
0
.58
%
0
.57
%
0
.58
%
0
.59
%
0
.59
%
Net
investment
income
1
.67
%
1
.06
%
1
.37
%
1
.70
%
2
.65
%
(3)
Portfolio
turnover
rate
83
.9
%
47
.8
%
87
.3
%
44
.8
%
65
.2
%
Net
assets,
end
of
period
(in
millions)
$18,698
$12,654
$8,901
$6,246
$3,696
0
%
0
%
0
%
0
%
0
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
7
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
Reflects
a
special
dividend
which
amounted
to
$0.30
per
share
and
1.04%
of
average
net
assets.
(4)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
(5)
See
Note
7
.
Prior
to
12/31/19,
the
gross
expense
ratios
presented
are
net
of
a
management
fee
waiver
in
effect
during
the
period,
as
applicable.
T.
ROWE
PRICE
Capital
Appreciation
Fund
December
31,
2022
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
ASSET-BACKED
SECURITIES
0.2%
Domino's
Pizza
Master
Issuer
Series 2017-1A,
Class
A23
4.118%,
7/25/47 (1)
38,742,938
35,505
Domino's
Pizza
Master
Issuer
Series 2018-1A,
Class
A2I
4.116%,
7/25/48 (1)
33,940,800
32,128
Domino's
Pizza
Master
Issuer
Series 2019-1A,
Class
A2
3.668%,
10/25/49 (1)
18,064,188
15,604
Total
Asset-Backed
Securities
(Cost
$90,426)
83,237
BANK
LOANS
12.9%
(2)
Acrisure,
FRN
1M
USD
LIBOR
+
3.75%,
8.134%,
2/15/27
25,235,563
23,919
ADMI,
FRN
1M
USD
LIBOR
+
3.38%,
7.759%,
12/23/27
56,965,295
51,525
ADMI,
FRN
1M
USD
LIBOR
+
3.75%,
8.134%,
12/23/27 (3)
135,650,910
123,189
ADMI,
FRN
3M
USD
LIBOR
+
3.00%,
4/30/25 (3)
16,873,615
15,848
Alliant
Holdings
Intermediate,
FRN
1M
USD
LIBOR
+
3.25%,
7.634%,
5/9/25 (3)
154,987,601
152,779
Alliant
Holdings
Intermediate,
FRN
1M
USD
LIBOR
+
3.25%,
7.634%,
5/9/25 (3)
75,025,227
73,967
Alliant
Holdings
Intermediate,
FRN
1M
USD
LIBOR
+
3.50%,
7.439%,
11/5/27 (3)
194,093,133
189,448
Applied
Systems,
FRN
1M
TSFR
+
4.50%,
9.08%,
9/18/26 (3)
235,698,421
234,617
Applied
Systems,
FRN
1M
USD
LIBOR
+
6.75%,
11.33%,
9/19/25 (3)
41,230,514
40,767
Ascend
Learning,
FRN
1M
USD
LIBOR
+
3.50%,
7.884%,
12/11/28
170,114,629
160,546
AthenaHealth
Group,
FRN
1M
TSFR
+
3.50%,
7.349%,
2/15/29 (4)
192,224,641
173,072
Avantor
Funding,
FRN
1M
USD
LIBOR
+
2.25%,
6.634%,
11/8/27 (3)
40,064,952
39,820
Azalea
Topco,
FRN
1M
TSFR
+
3.75%,
8.173%,
7/24/26
26,089,546
23,872
Azalea
Topco,
FRN
1M
USD
LIBOR
+
3.50%,
7.884%,
7/24/26
142,896,095
130,571
Azalea
Topco,
FRN
1M
USD
LIBOR
+
3.75%,
8.134%,
7/24/26 (3)
39,969,625
36,639
Camelot
U.S.
Acquisition,
FRN
1M
USD
LIBOR
+
3.00%,
7.384%,
10/30/26
22,618,700
22,251
T.
ROWE
PRICE
Capital
Appreciation
Fund
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
Charter
Communications
Operating,
FRN
1M
USD
LIBOR
+
1.75%,
6.14%,
4/30/25
22,860,311
22,707
CoreLogic,
FRN
1M
USD
LIBOR
+
6.50%,
10.938%,
6/4/29
5,985,000
4,192
Eyecare
Partners,
FRN
1M
TSFR
+
3.75%,
8.48%,
2/18/27
9,928,363
7,910
Eyecare
Partners,
FRN
1M
TSFR
+
3.75%,
8.48%,
11/15/28
4,841,602
4,060
Filtration
Group,
FRN
1M
USD
LIBOR
+
3.50%,
7.884%,
10/21/28 (3)
59,545,935
58,355
Filtration
Group,
FRN
3M
EURIBOR
+
3.50%,
5.398%,
3/31/25
(EUR)
50,688,540
52,316
Filtration
Group,
FRN
3M
USD
LIBOR
+
3.00%,
7.384%,
3/31/25 (3)
74,496,260
73,596
Heartland
Dental,
FRN
1M
USD
LIBOR
+
4.00%,
8.387%,
4/30/25
20,396,751
18,918
Heartland
Dental,
FRN
3M
USD
LIBOR
+
3.75%,
8.134%,
4/30/25
168,692,519
155,534
Hilton
Worldwide
Finance,
FRN
1M
USD
LIBOR
+
1.75%,
6.173%,
6/22/26 (3)
21,002,377
20,919
Howden
Group
Holdings,
FRN
1M
USD
LIBOR
+
3.25%,
7.688%,
11/12/27
163,805,254
159,271
HUB
International,
FRN
1M
TSFR
+
4.00%,
8.22%,
11/10/29
44,788,823
44,254
HUB
International,
FRN
1M
USD
LIBOR
+
3.25%,
7.528%,
4/25/25
520,951,529
515,622
HUB
International,
FRN
3M
USD
LIBOR
+
3.00%,
7.327%,
4/25/25
767,567,336
758,295
IRB
Holding,
FRN
1M
TSFR
+
3.00%,
7.317%,
12/15/27
67,092,611
65,029
IRB
Holding,
FRN
1M
USD
LIBOR
+
2.75%,
7.134%,
2/5/25 (3)
68,221,758
67,529
Life
Time,
FRN
1M
USD
LIBOR
+
4.75%,
9.485%,
12/16/24
19,802,638
19,673
Loire
Finco
Luxembourg,
FRN
1M
USD
LIBOR
+
3.00%,
7.384%,
4/21/27 (3)
109,846,058
102,294
Loire
Finco
Luxembourg,
FRN
1M
USD
LIBOR
+
3.50%,
7.884%,
4/21/27
6,709,342
6,251
Medline
Borrower,
FRN
1M
USD
LIBOR
+
3.25%,
7.634%,
10/23/28
346,660,916
328,974
Mileage
Plus
Holdings,
FRN
1M
USD
LIBOR
+
5.25%,
9.996%,
6/21/27 (3)
218,759,574
224,721
PetVet
Care
Centers,
FRN
1M
USD
LIBOR
+
3.50%,
7.884%,
2/14/25
74,252,584
69,578
PetVet
Care
Centers,
FRN
3M
USD
LIBOR
+
2.75%,
7.134%,
2/14/25
11,463,917
10,669
T.
ROWE
PRICE
Capital
Appreciation
Fund
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
PetVet
Care
Centers,
FRN
3M
USD
LIBOR
+
3.25%,
7.634%,
2/14/25
48,633,636
45,366
PetVet
Care
Centers,
FRN
3M
USD
LIBOR
+
6.25%,
10.634%,
2/13/26
3,982,000
3,660
RealPage,
FRN
1M
USD
LIBOR
+
3.00%,
7.384%,
4/24/28
185,409,820
175,954
RealPage,
FRN
1M
USD
LIBOR
+
6.50%,
10.884%,
4/23/29
6,300,000
6,032
Ryan
Specialty
Group,
FRN
1M
TSFR
+
3.00%,
7.423%,
9/1/27
36,751,819
36,446
SBA
Senior
Finance
II,
FRN
1M
USD
LIBOR
+
1.75%,
6.14%,
4/11/25 (3)
11,060,169
11,011
SeaWorld
Parks
&
Entertainment,
FRN
1M
USD
LIBOR
+
3.00%,
7.438%,
8/25/28
5,972,792
5,857
SkyMiles
IP,
FRN
3M
USD
LIBOR
+
3.75%,
6.46%,
10/20/27 (3)
56,961,329
57,986
Sophia,
FRN
1M
TSFR
+
4.25%,
8.573%,
10/7/27 (3)
16,504,064
16,009
Sophia,
FRN
1M
USD
LIBOR
+
3.50%,
8.23%,
10/7/27 (3)
36,736,747
35,382
Storable,
FRN
1M
TSFR
+
3.50%,
7.978%,
4/17/28
9,405,000
8,935
Sunshine
Luxembourg
VII,
FRN
1M
USD
LIBOR
+
3.75%,
8.48%,
10/1/26
118,627,443
113,421
TK
Elevator
U.S.
Newco,
FRN
6M
USD
LIBOR
+
3.50%,
6.871%,
7/30/27
72,710,691
69,848
UKG,
FRN
1M
USD
LIBOR
+
3.25%,
6.998%,
5/4/26
638,573,594
606,645
UKG,
FRN
1M
USD
LIBOR
+
5.25%,
8.998%,
5/3/27
32,910,000
30,129
USI,
FRN
1M
TSFR
+
3.25%,
7.98%,
12/2/26 (3)
183,612,613
182,006
USI,
FRN
1M
TSFR
+
3.75%,
8.33%,
11/22/29
165,840,969
164,065
Woof
Holdings,
FRN
1M
USD
LIBOR
+
3.75%,
8.104%,
12/21/27
18,412,050
17,277
Total
Bank
Loans
(Cost
$6,046,321)
5,869,526
BOND
MUTUAL
FUNDS
1.6%
T.
Rowe
Price
Institutional
Floating
Rate
Fund
–
Institutional
Class,
7.57% (5)(6)
81,623,366
749,303
Total
Bond
Mutual
Funds
(Cost
$791,539)
749,303
T.
ROWE
PRICE
Capital
Appreciation
Fund
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
COMMON
STOCKS
61.9%
COMMUNICATION
SERVICES
1.8%
Interactive
Media
&
Services
1.8%
Alphabet,
Class
A (7)(8)
7,392,840
652,270
Meta
Platforms,
Class
A (7)
1,421,485
171,062
Total
Communication
Services
823,332
CONSUMER
DISCRETIONARY
4.7%
Auto
Components
0.1%
Mobileye
Global,
Class
A (7)
771,493
27,049
27,049
Hotels,
Restaurants
&
Leisure
2.5%
Starbucks (8)
2,365,800
234,687
Yum!
Brands (8)
6,963,386
891,871
1,126,558
Internet
&
Direct
Marketing
Retail
2.1%
Amazon.com (7)(8)
11,249,700
944,975
944,975
Total
Consumer
Discretionary
2,098,582
CONSUMER
STAPLES
0.3%
Beverages
0.3%
Keurig
Dr
Pepper (8)
4,286,745
152,865
Total
Consumer
Staples
152,865
ENERGY
1.6%
Oil,
Gas
&
Consumable
Fuels
1.6%
ConocoPhillips
995,648
117,487
EOG
Resources
3,247,405
420,604
Pioneer
Natural
Resources
888,700
202,970
Total
Energy
741,061
FINANCIALS
6.8%
Banks
2.9%
PNC
Financial
Services
Group (8)
8,306,093
1,311,864
1,311,864
Capital
Markets
3.2%
Intercontinental
Exchange
8,304,785
851,988
KKR
8,171,371
379,315
MSCI
139,154
64,730
S&P
Global
442,390
148,174
1,444,207
T.
ROWE
PRICE
Capital
Appreciation
Fund
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
Insurance
0.7%
Marsh
&
McLennan
2,049,018
339,071
339,071
Total
Financials
3,095,142
HEALTH
CARE
13.0%
Health
Care
Equipment
&
Supplies
3.5%
Alcon
(CHF)
6,965,090
477,937
Becton
Dickinson
&
Company
2,270,944
577,501
Teleflex
2,087,469
521,095
1,576,533
Health
Care
Providers
&
Services
2.0%
UnitedHealth
Group (8)
1,693,153
897,676
897,676
Health
Care
Technology
0.1%
GE
HealthCare
Technologies (7)(9)
1,037,059
60,543
60,543
Life
Sciences
Tools
&
Services
6.5%
Avantor (7)
25,653,194
541,026
Danaher
2,707,794
718,703
PerkinElmer
5,868,147
822,831
Thermo
Fisher
Scientific (8)
1,548,504
852,746
2,935,306
Pharmaceuticals
0.9%
Catalent (7)
2,807,132
126,349
Eli
Lilly
773,500
282,977
409,326
Total
Health
Care
5,879,384
INDUSTRIALS
&
BUSINESS
SERVICES
10.4%
Commercial
Services
&
Supplies
1.4%
Aurora
Innovation (7)
34,667,381
41,948
Waste
Connections
4,439,653
588,520
630,468
Industrial
Conglomerates
2.9%
General
Electric (8)
9,298,452
779,117
Roper
Technologies
1,291,022
557,838
1,336,955
Machinery
3.5%
Fortive
13,819,498
887,903
Ingersoll
Rand
13,620,570
711,675
1,599,578
T.
ROWE
PRICE
Capital
Appreciation
Fund
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
Professional
Services
2.6%
Equifax
3,106,947
603,866
TransUnion (5)
10,150,553
576,044
1,179,910
Total
Industrials
&
Business
Services
4,746,911
INFORMATION
TECHNOLOGY
16.3%
Electronic
Equipment,
Instruments
&
Components
2.6%
TE
Connectivity (8)
5,841,845
670,644
Teledyne
Technologies (7)
1,324,093
529,518
1,200,162
IT
Services
1.4%
Mastercard,
Class
A
965,000
335,559
Visa,
Class
A
1,385,400
287,831
623,390
Semiconductors
&
Semiconductor
Equipment
3.8%
NVIDIA
1,885,000
275,474
NXP
Semiconductors
5,153,173
814,356
Texas
Instruments
3,912,129
646,362
1,736,192
Software
6.1%
Microsoft (8)
9,922,427
2,379,597
Salesforce (7)
3,022,348
400,733
2,780,330
Technology
Hardware,
Storage
&
Peripherals
2.4%
Apple (8)
8,505,614
1,105,134
1,105,134
Total
Information
Technology
7,445,208
MATERIALS
1.0%
Chemicals
1.0%
Linde
1,360,722
443,840
Total
Materials
443,840
UTILITIES
2.7%
Electric
Utilities
0.8%
Xcel
Energy
5,227,400
366,493
366,493
Multi-Utilities
1.9%
Ameren
7,512,144
667,980
T.
ROWE
PRICE
Capital
Appreciation
Fund
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
Public
Service
Enterprise
Group
2,857,600
175,085
843,065
Total
Utilities
1,209,558
Total
Miscellaneous
Common
Stocks
3.3% (10)
1,500,950
Total
Common
Stocks
(Cost
$23,003,936)
28,136,833
CONVERTIBLE
BONDS
0.1%
Spotify
USA,
Zero
Coupon,
3/15/26
44,593,000
36,086
Total
Convertible
Bonds
(Cost
$39,179)
36,086
CONVERTIBLE
PREFERRED
STOCKS
0.2%
INFORMATION
TECHNOLOGY
0.2%
Software
0.2%
Waymo,
Series
A-2,
Acquisition
Date:
5/8/20,
Cost $183,922 (7)
(11)(12)
2,141,932
101,057
Waymo,
Series
B-2,
Acquisition
Date:
6/11/21,
Cost $16,282 (7)
(11)(12)
177,514
8,375
Total
Information
Technology
109,432
Total
Convertible
Preferred
Stocks
(Cost
$200,204)
109,432
CORPORATE
BONDS
8.2%
Acrisure,
7.00%,
11/15/25 (1)
76,025,000
69,943
Alliant
Holdings
Intermediate,
4.25%,
10/15/27 (1)
14,533,000
13,043
Alliant
Holdings
Intermediate,
5.875%,
11/1/29 (1)
22,668,000
18,588
Alliant
Holdings
Intermediate,
6.75%,
10/15/27 (1)
74,350,000
66,822
Altice
France
Holding,
10.50%,
5/15/27 (1)
56,255,000
42,754
AmWINS
Group,
4.875%,
6/30/29 (1)
20,805,000
17,814
Arches
Buyer,
4.25%,
6/1/28 (1)
300,000
234
Avantor
Funding,
3.875%,
11/1/29 (1)
62,293,000
52,248
Avantor
Funding,
4.625%,
7/15/28 (1)
89,838,000
81,640
Black
Knight
InfoServ,
3.625%,
9/1/28 (1)
10,398,000
9,020
Booz
Allen
Hamilton,
3.875%,
9/1/28 (1)
13,089,000
11,600
Booz
Allen
Hamilton,
4.00%,
7/1/29 (1)
1,602,000
1,412
BroadStreet
Partners,
5.875%,
4/15/29 (1)
7,405,000
6,331
CCO
Holdings,
5.00%,
2/1/28 (1)
252,238,000
227,014
CCO
Holdings,
5.125%,
5/1/27 (1)
321,632,000
296,303
CCO
Holdings,
5.50%,
5/1/26 (1)
12,750,000
12,336
Cedar
Fair,
5.25%,
7/15/29
75,398,000
67,670
Cedar
Fair,
5.375%,
4/15/27
95,041,000
90,408
Cedar
Fair,
5.50%,
5/1/25 (1)
59,601,000
58,707
Cedar
Fair,
6.50%,
10/1/28
64,276,000
61,625
T.
ROWE
PRICE
Capital
Appreciation
Fund
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
Charles
River
Laboratories
International,
3.75%,
3/15/29 (1)
23,081,000
20,311
Charles
River
Laboratories
International,
4.00%,
3/15/31 (1)
14,433,000
12,521
Charles
River
Laboratories
International,
4.25%,
5/1/28 (1)
6,559,000
6,002
Clarios
Global,
6.25%,
5/15/26 (1)
21,486,000
21,003
Clarios
Global,
6.75%,
5/15/25 (1)
15,558,000
15,616
Clarios
Global,
8.50%,
5/15/27 (1)
76,610,000
74,886
Clarivate
Science
Holdings,
3.875%,
7/1/28 (1)
10,532,000
8,979
Clarivate
Science
Holdings,
4.875%,
7/1/29 (1)
7,515,000
6,369
Crowdstrike
Holdings,
3.00%,
2/15/29
2,555,000
2,152
Delta
Air
Lines,
4.75%,
10/20/28 (1)
37,425,000
35,138
Entegris
Escrow,
4.75%,
4/15/29 (1)
17,728,000
16,066
Gartner,
3.625%,
6/15/29 (1)
29,541,000
25,885
Gartner,
3.75%,
10/1/30 (1)
12,944,000
11,148
Gartner,
4.50%,
7/1/28 (1)
6,360,000
5,915
General
Electric,
Series D,
FRN,
3M
USD
LIBOR
+
3.33%,
8.099% (13)
148,338,000
147,040
Hadrian
Merger
Sub,
8.50%,
5/1/26 (1)
65,911,000
57,343
Hilton
Domestic
Operating,
3.625%,
2/15/32 (1)
37,792,000
30,281
Hilton
Domestic
Operating,
3.75%,
5/1/29 (1)
20,727,000
17,929
Hilton
Domestic
Operating,
4.00%,
5/1/31 (1)
28,046,000
23,558
Hilton
Domestic
Operating,
4.875%,
1/15/30
28,043,000
25,344
Hilton
Domestic
Operating,
5.375%,
5/1/25 (1)
10,803,000
10,668
Hilton
Domestic
Operating,
5.75%,
5/1/28 (1)
7,941,000
7,683
Hilton
Worldwide
Finance,
4.875%,
4/1/27
14,587,000
13,876
Hologic,
3.25%,
2/15/29 (1)
23,573,000
20,273
Howmet
Aerospace,
3.00%,
1/15/29
21,568,000
18,603
Howmet
Aerospace,
5.90%,
2/1/27
3,203,000
3,203
HUB
International,
5.625%,
12/1/29 (1)
17,893,000
15,656
HUB
International,
7.00%,
5/1/26 (1)
306,293,000
299,784
Intercontinental
Exchange,
4.00%,
9/15/27
6,439,000
6,221
Intercontinental
Exchange,
4.35%,
6/15/29
21,763,000
21,041
Intercontinental
Exchange,
5.20%,
6/15/62
43,315,000
40,867
IQVIA,
5.00%,
5/15/27 (1)
14,625,000
13,857
KFC
Holding,
4.75%,
6/1/27 (1)
135,551,000
130,129
Korn
Ferry,
4.625%,
12/15/27 (1)
11,955,000
10,969
Lamar
Media,
3.625%,
1/15/31
4,650,000
3,813
Lamar
Media,
3.75%,
2/15/28
26,928,000
24,033
Lennox
International,
3.00%,
11/15/23
6,420,000
6,298
Life
Time,
5.75%,
1/15/26 (1)
52,089,000
48,182
Live
Nation
Entertainment,
4.875%,
11/1/24 (1)
3,645,000
3,531
Mattel,
3.375%,
4/1/26 (1)
7,552,000
6,920
Mattel,
3.75%,
4/1/29 (1)
16,096,000
14,084
Mattel,
5.875%,
12/15/27 (1)
5,795,000
5,657
Mileage
Plus
Holdings,
6.50%,
6/20/27 (1)
35,507,288
35,108
Mirant,
EC,
7.90%,
7/15/09 (1)(7)(11)
16,000,000
—
MSCI,
3.25%,
8/15/33 (1)
17,534,000
13,545
T.
ROWE
PRICE
Capital
Appreciation
Fund
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
MSCI,
3.625%,
9/1/30 (1)
45,782,000
37,999
MSCI,
3.625%,
11/1/31 (1)
19,344,000
16,055
MSCI,
3.875%,
2/15/31 (1)
23,764,000
19,694
MSCI,
4.00%,
11/15/29 (1)
31,775,000
27,724
NiSource,
VR,
5.65% (13)(14)
20,039,000
18,636
PRA
Health
Sciences,
2.875%,
7/15/26 (1)
7,641,000
6,972
Ryan
Specialty
Group,
4.375%,
2/1/30 (1)
2,890,000
2,511
SBA
Communications,
3.125%,
2/1/29
48,386,000
40,221
SBA
Communications,
3.875%,
2/15/27
34,256,000
31,087
SBA
Tower
Trust,
6.599%,
1/15/28 (1)
2,575,000
2,579
Sensata
Technologies,
3.75%,
2/15/31 (1)
20,020,000
16,467
Sensata
Technologies,
4.00%,
4/15/29 (1)
37,430,000
32,283
Sensata
Technologies,
4.375%,
2/15/30 (1)
8,826,000
7,712
Sensata
Technologies,
5.00%,
10/1/25 (1)
23,800,000
23,086
Sensata
Technologies,
5.625%,
11/1/24 (1)
6,670,000
6,587
Sensata
Technologies,
5.875%,
9/1/30 (1)
10,247,000
9,683
Service
Corp.
International,
3.375%,
8/15/30
25,751,000
20,923
Sirius
XM
Radio,
5.00%,
8/1/27 (1)
15,665,000
14,471
Six
Flags
Entertainment,
4.875%,
7/31/24 (1)
186,526,000
179,998
Six
Flags
Entertainment,
5.50%,
4/15/27 (1)
115,949,000
105,803
Six
Flags
Theme
Parks,
7.00%,
7/1/25 (1)
29,908,000
30,057
Surgery
Center
Holdings,
10.00%,
4/15/27 (1)
29,147,000
29,439
Teleflex,
4.25%,
6/1/28 (1)
5,425,000
4,991
Teleflex,
4.625%,
11/15/27
31,460,000
29,808
TransDigm,
5.50%,
11/15/27
27,161,000
25,260
TransDigm,
6.25%,
3/15/26 (1)
35,666,000
34,997
TransDigm,
6.375%,
6/15/26
5,780,000
5,628
TransDigm
U.K.
Holdings,
6.875%,
5/15/26
3,025,000
2,972
Twilio,
3.625%,
3/15/29
1,215,000
986
U.S.
Airways
PTT,
Series 2010-1,
Class
A,
6.25%,
4/22/23
4,170,556
4,087
U.S.
Airways
PTT,
Series 2012-2,
Class
A,
4.625%,
6/3/25
822,229
744
U.S.
Airways
PTT,
Series 2013-1,
Class
A,
3.95%,
11/15/25
4,866,607
4,435
United
Airlines
PTT,
Series 2012-1,
Class
A,
4.15%,
4/11/24
7,813,296
7,563
USI,
6.875%,
5/1/25 (1)
119,087,000
116,557
Vail
Resorts,
6.25%,
5/15/25 (1)
10,632,000
10,632
Yum!
Brands,
3.625%,
3/15/31
34,665,000
28,945
Yum!
Brands,
4.625%,
1/31/32
70,819,000
62,675
Yum!
Brands,
4.75%,
1/15/30 (1)
23,469,000
21,533
Yum!
Brands,
5.35%,
11/1/43
72,633,000
60,013
Yum!
Brands,
5.375%,
4/1/32
54,315,000
50,241
Yum!
Brands,
6.875%,
11/15/37
30,316,000
30,695
Total
Corporate
Bonds
(Cost
$3,907,363)
3,725,748
T.
ROWE
PRICE
Capital
Appreciation
Fund
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
PREFERRED
STOCKS
0.3%
FINANCIALS
0.0%
Financial
Services
0.0%
Charles
Schwab,
Series
D,
5.95% (13)
95,800
2,260
Total
Financials
2,260
UTILITIES
0.3%
Electric
Utilities
0.3%
CMS
Energy,
5.875%,
10/15/78 (5)
2,242,179
49,731
CMS
Energy,
5.875%,
3/1/79 (5)
2,745,976
61,510
SCE
Trust
IV,
Series
J,
VR,
5.375% (5)(13)(14)
1,637,355
29,636
140,877
Gas
&
Gas
Transmission
0.0%
NiSource,
Series
B,
VR,
6.50% (13)(14)
514,812
12,505
12,505
Total
Utilities
153,382
Total
Preferred
Stocks
(Cost
$180,903)
155,642
U.S.
GOVERNMENT
AGENCY
OBLIGATIONS
(EXCLUDING
MORTGAGE-BACKED)
9.0%
U.S.
Treasury
Obligations
9.0%
U.S.
Treasury
Notes,
2.75%,
8/15/32
4,473,285,900
4,068,593
4,068,593
Total
U.S.
Government
Agency
Obligations
(Excluding
Mortgage-Backed)
(Cost
$4,067,120)
4,068,593
SHORT-TERM
INVESTMENTS
6.0%
Money
Market
Funds
6.0%
T.
Rowe
Price
Government
Reserve
Fund,
4.30% (5)(15)
2,714,515,328
2,714,515
Total
Short-Term
Investments
(Cost
$2,714,515)
2,714,515
Total
Investments
in
Securities
100.4%
of
Net
Assets
(Cost
$41,041,506)
$
45,648,915
‡
Shares/Par
and
Notional
Amount
are
denominated
in
U.S.
dollars
unless
otherwise
noted.
T.
ROWE
PRICE
Capital
Appreciation
Fund
.
.
.
.
.
.
.
.
.
.
(1)
Security
was
purchased
pursuant
to
Rule
144A
under
the
Securities
Act
of
1933
and
may
be
resold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers.
Total
value
of
such
securities
at
period-end
amounts
to
$2,851,872
and
represents
6.3%
of
net
assets.
(2)
Bank
loan
positions
may
involve
multiple
underlying
tranches.
In
those
instances,
the
position
presented
reflects
the
aggregate
of
those
respective
underlying
tranches
and
the
rate
presented
reflects
the
weighted
average
rate
of
the
settled
positions.
(3)
All
or
a
portion
of
this
loan
is
unsettled
as
of
December
31,
2022.
The
interest
rate
for
unsettled
loans
will
be
determined
upon
settlement
after
period
end.
(4)
All
or
a
portion
of
the
position
represents
an
unfunded
commitment;
a
liability
to
fund
the
commitment
has
been
recognized.
The
fund's
total
unfunded
commitment
at
December
31,
2022,
was
$20,984
and
was
valued
at
$18,893
(0.0%
of
net
assets).
(5)
Affiliated
Companies
(6)
SEC
30-day
yield
(7)
Non-income
producing
(8)
All
or
a
portion
of
this
security
is
pledged
to
cover
or
as
collateral
for
written
call
options
at
December
31,
2022.
(9)
When-issued
security
(10)
The
identity
of
certain
securities
has
been
concealed
to
protect
the
fund
while
it
completes
a
purchase
or
selling
program
for
the
securities.
(11)
See
Note
2.
Level
3
in
fair
value
hierarchy.
(12)
Security
cannot
be
offered
for
public
resale
without
first
being
registered
under
the
Securities
Act
of
1933
and
related
rules
("restricted
security").
Acquisition
date
represents
the
day
on
which
an
enforceable
right
to
acquire
such
security
is
obtained
and
is
presented
along
with
related
cost
in
the
security
description.
The
fund
may
have
registration
rights
for
certain
restricted
securities.
Any
costs
related
to
such
registration
are
generally
borne
by
the
issuer.
The
aggregate
value
of
restricted
securities
(excluding
144A
holdings)
at
period
end
amounts
to
$109,432
and
represents
0.2%
of
net
assets.
(13)
Perpetual
security
with
no
stated
maturity
date.
(14)
Security
is
a
fix-to-float
security,
which
carries
a
fixed
coupon
until
a
certain
date,
upon
which
it
switches
to
a
floating
rate.
Reference
rate
and
spread
are
provided
if
the
rate
is
currently
floating.
(15)
Seven-day
yield
1M
TSFR
One
month
term
SOFR
(Secured
overnight
financing
rate)
1M
USD
LIBOR
One
month
USD
LIBOR
(London
interbank
offered
rate)
3M
EURIBOR
Three
month
EURIBOR
(Euro
interbank
offered
rate)
3M
USD
LIBOR
Three
month
USD
LIBOR
(London
interbank
offered
rate)
6M
USD
LIBOR
Six
month
USD
LIBOR
(London
interbank
offered
rate)
CHF
Swiss
Franc
EC
Escrow
CUSIP;
represents
a
beneficial
interest
in
a
residual
pool
of
assets;
the
amount
and
timing
of
future
distributions,
if
any,
is
uncertain;
when
presented,
interest
rate
and
maturity
date
are
those
of
the
original
security.
EUR
Euro
FRN
Floating
Rate
Note
T.
ROWE
PRICE
Capital
Appreciation
Fund
.
.
.
.
.
.
.
.
.
.
OTC
Over-the-counter
PTT
Pass-Through
Trust
VR
Variable
Rate;
rate
shown
is
effective
rate
at
period-end.
The
rates
for
certain
variable
rate
securities
are
not
based
on
a
published
reference
rate
and
spread
but
are
determined
by
the
issuer
or
agent
and
based
on
current
market
conditions.
T.
ROWE
PRICE
Capital
Appreciation
Fund
(Amounts
in
000s,
except
for
contracts)
OPTIONS
WRITTEN
(0.2)%
OTC
Options
Written
(0.2)%
Counterparty
Description
Contracts
Notional
Amount
$
Value
Goldman
Sachs
Alphabet,
Class
A,
Call,
1/20/23
@
$160.00
2,380
20,999
(1)
Goldman
Sachs
Alphabet,
Class
A,
Call,
1/20/23
@
$165.00
2,380
20,999
(1)
Goldman
Sachs
Alphabet,
Class
A,
Call,
1/20/23
@
$170.00
2,380
20,999
(1)
Goldman
Sachs
Alphabet,
Class
A,
Call,
1/20/23
@
$175.00
2,380
20,999
(1)
Wells
Fargo
Bank
Alphabet,
Class
A,
Call,
1/19/24
@
$120.00
11,767
103,820
(4,736)
Citibank
Amazon.com,
Call,
1/20/23
@
$225.00
1,260
10,584
(1)
Citibank
Amazon.com,
Call,
1/20/23
@
$230.00
1,260
10,584
(1)
Citibank
Amazon.com,
Call,
1/20/23
@
$235.00
1,260
10,584
(1)
Citibank
Amazon.com,
Call,
1/20/23
@
$240.00
1,260
10,584
(1)
Citibank
Amazon.com,
Call,
1/20/23
@
$245.00
1,260
10,584
(1)
Citibank
Amazon.com,
Call,
1/20/23
@
$250.00
1,260
10,584
(1)
Citibank
Amazon.com,
Call,
1/20/23
@
$255.00
1,260
10,584
(1)
Goldman
Sachs
Amazon.com,
Call,
1/20/23
@
$180.00
1,860
15,624
(1)
Goldman
Sachs
Amazon.com,
Call,
1/20/23
@
$185.00
1,860
15,624
(1)
Goldman
Sachs
Amazon.com,
Call,
1/20/23
@
$190.00
1,860
15,624
(1)
Goldman
Sachs
Amazon.com,
Call,
1/20/23
@
$200.00
1,220
10,248
(1)
Goldman
Sachs
Amazon.com,
Call,
1/20/23
@
$205.00
1,220
10,248
(1)
Goldman
Sachs
Amazon.com,
Call,
1/20/23
@
$210.00
1,220
10,248
(1)
Goldman
Sachs
Amazon.com,
Call,
1/20/23
@
$215.00
1,220
10,248
(1)
Goldman
Sachs
Amazon.com,
Call,
1/20/23
@
$220.00
1,220
10,248
(1)
Goldman
Sachs
Amazon.com,
Call,
1/20/23
@
$225.00
1,220
10,248
(1)
T.
ROWE
PRICE
Capital
Appreciation
Fund
(Amounts
in
000s,
except
for
contracts)
Counterparty
Description
Contracts
Notional
Amount
$
Value
Wells
Fargo
Bank
Amazon.com,
Call,
1/20/23
@
$175.00
8,400
70,560
(4)
Wells
Fargo
Bank
Amazon.com,
Call,
1/20/23
@
$190.00
3,200
26,880
(2)
Wells
Fargo
Bank
Amazon.com,
Call,
1/20/23
@
$195.00
3,200
26,880
(2)
Wells
Fargo
Bank
Amazon.com,
Call,
1/20/23
@
$200.00
3,200
26,880
(2)
Wells
Fargo
Bank
Amazon.com,
Call,
1/20/23
@
$205.00
3,200
26,880
(2)
Wells
Fargo
Bank
Amazon.com,
Call,
1/20/23
@
$210.00
3,200
26,880
(2)
JPMorgan
Chase
Apple,
Call,
1/20/23
@
$170.00
5,100
66,264
(8)
JPMorgan
Chase
Apple,
Call,
1/20/23
@
$175.00
5,100
66,264
(8)
JPMorgan
Chase
Apple,
Call,
1/20/23
@
$180.00
5,100
66,264
(2)
Wells
Fargo
Bank
General
Electric,
Call,
1/20/23
@
$85.00
7,280
60,999
(1,401)
Wells
Fargo
Bank
General
Electric,
Call,
1/20/23
@
$90.00
7,280
60,999
(353)
Wells
Fargo
Bank
General
Electric,
Call,
1/20/23
@
$95.00
7,280
60,999
(69)
Wells
Fargo
Bank
General
Electric,
Call,
1/20/23
@
$110.00
9,609
80,514
(24)
Wells
Fargo
Bank
Hilton
Worldwide
Holdings,
Call,
1/19/24
@
$145.00
3,037
38,376
(3,690)
Wells
Fargo
Bank
Hilton
Worldwide
Holdings,
Call,
1/19/24
@
$150.00
3,037
38,376
(3,219)
Citibank
Keurig
Dr
Pepper,
Call,
1/20/23
@
$40.00
7,350
26,210
(18)
Citibank
Keurig
Dr
Pepper,
Call,
1/20/23
@
$42.00
7,350
26,210
(18)
Citibank
Microsoft,
Call,
1/20/23
@
$325.00
4,370
104,801
(2)
Citibank
Microsoft,
Call,
1/20/23
@
$330.00
2,142
51,369
(1)
Citibank
Microsoft,
Call,
1/20/23
@
$340.00
4,452
106,768
(2)
Citibank
Microsoft,
Call,
1/20/23
@
$350.00
4,452
106,768
(2)
Citibank
Microsoft,
Call,
1/20/23
@
$360.00
2,310
55,398
(1)
T.
ROWE
PRICE
Capital
Appreciation
Fund
(Amounts
in
000s,
except
for
contracts)
Counterparty
Description
Contracts
Notional
Amount
$
Value
Citibank
Microsoft,
Call,
1/20/23
@
$365.00
1,603
38,443
(1)
Credit
Suisse
Microsoft,
Call,
1/20/23
@
$320.00
2,277
54,607
(3)
Credit
Suisse
Microsoft,
Call,
1/20/23
@
$330.00
1,372
32,903
(1)
Credit
Suisse
Microsoft,
Call,
1/20/23
@
$340.00
1,372
32,903
(1)
Credit
Suisse
Microsoft,
Call,
1/20/23
@
$350.00
1,372
32,903
(1)
JPMorgan
Chase
Microsoft,
Call,
1/20/23
@
$350.00
2,320
55,638
(1)
JPMorgan
Chase
Microsoft,
Call,
1/20/23
@
$355.00
2,320
55,638
(1)
JPMorgan
Chase
Microsoft,
Call,
1/20/23
@
$360.00
2,321
55,662
(1)
JPMorgan
Chase
Microsoft,
Call,
1/19/24
@
$300.00
9,507
227,997
(11,741)
Susquehanna
Financial
Group
LLLP
Microsoft,
Call,
1/20/23
@
$330.00
905
21,704
—
Susquehanna
Financial
Group
LLLP
Microsoft,
Call,
1/20/23
@
$340.00
905
21,704
—
Susquehanna
Financial
Group
LLLP
Microsoft,
Call,
1/20/23
@
$350.00
905
21,704
—
Citibank
PNC
Financial
Services
Group,
Call,
1/20/23
@
$220.00
3,221
50,872
(16)
Citibank
PNC
Financial
Services
Group,
Call,
1/20/23
@
$230.00
3,221
50,873
(8)
JPMorgan
Chase
PNC
Financial
Services
Group,
Call,
1/20/23
@
$190.00
1,946
30,735
(24)
JPMorgan
Chase
PNC
Financial
Services
Group,
Call,
1/20/23
@
$195.00
1,946
30,735
(34)
JPMorgan
Chase
PNC
Financial
Services
Group,
Call,
1/20/23
@
$200.00
1,946
30,735
(24)
Goldman
Sachs
Starbucks,
Call,
1/20/23
@
$97.50
5,442
53,985
(2,013)
Goldman
Sachs
Starbucks,
Call,
1/20/23
@
$100.00
5,442
53,985
(1,219)
Goldman
Sachs
Starbucks,
Call,
1/20/23
@
$105.00
5,442
53,985
(321)
T.
ROWE
PRICE
Capital
Appreciation
Fund
(Amounts
in
000s,
except
for
contracts)
Counterparty
Description
Contracts
Notional
Amount
$
Value
Goldman
Sachs
Starbucks,
Call,
1/19/24
@
$100.00
3,666
36,367
(4,977)
Goldman
Sachs
Starbucks,
Call,
1/19/24
@
$105.00
3,666
36,367
(4,115)
JPMorgan
Chase
TE
Connectivity,
Call,
1/20/23
@
$120.00
5,810
66,699
(668)
Citibank
Thermo
Fisher
Scientific,
Call,
1/20/23
@
$640.00
961
52,921
(48)
Citibank
UnitedHealth
Group,
Call,
1/20/23
@
$540.00
1,794
95,114
(1,467)
Citibank
UnitedHealth
Group,
Call,
1/20/23
@
$560.00
1,014
53,760
(259)
Citibank
UnitedHealth
Group,
Call,
1/20/23
@
$580.00
1,014
53,760
(70)
Citibank
UnitedHealth
Group,
Call,
1/19/24
@
$580.00
2,096
111,126
(8,698)
JPMorgan
Chase
UnitedHealth
Group,
Call,
1/19/24
@
$600.00
2,209
117,117
(8,019)
Citibank
Yum!
Brands,
Call,
1/19/24
@
$145.00
2,241
28,703
(1,748)
Citibank
Yum!
Brands,
Call,
1/19/24
@
$150.00
2,241
28,703
(1,378)
Wells
Fargo
Bank
Yum!
Brands,
Call,
1/20/23
@
$145.00
2,042
26,154
(10)
Wells
Fargo
Bank
Yum!
Brands,
Call,
1/20/23
@
$150.00
2,042
26,154
(5)
Wells
Fargo
Bank
Yum!
Brands,
Call,
1/19/24
@
$140.00
9,000
115,272
(8,775)
Total
Options
Written
(Premiums
$(240,046))
$
(69,235)
T.
ROWE
PRICE
Capital
Appreciation
Fund
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
year
ended
December
31,
2022.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
CMS
Energy,
5.875%,
10/15/78��
$
(396)
$
(11,661)
$
3,890
CMS
Energy,
5.875%,
3/1/79
(660)
(15,008)
5,079
Fortive
(29,843)
54,583
4,153
NiSource,
VR,
5.65%
(1,957)
(2,894)
2,266
NiSource,
Series
B,
VR,
6.50%
777
(3,482)
1,465
PerkinElmer
(118,838)
(235,483)
2,083
SCE
Trust
IV,
Series
J,
VR,
5.375%
(1,551)
(11,417)
2,430
T.
Rowe
Price
Institutional
Floating
Rate
Fund
–
Institutional
Class,
7.57%
—
(42,559)
39,056
TransUnion
(1,665)
(279,725)
2,682
T.
Rowe
Price
Government
Reserve
Fund,
4.30%
—
—
47,520
Affiliates
not
held
at
period
end
61,468
(45,767)
6,195
Totals
$
(92,665)#
$
(593,413)
$
116,819+
T.
ROWE
PRICE
Capital
Appreciation
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
AFFILIATED
COMPANIES
(CONTINUED)
($000s)
Supplementary
Investment
Schedule
Affiliate
Value
12/31/21
Purchase
Cost
Sales
Cost
Value
12/31/22
CMS
Energy
$
562,429
$
—
$
524,477
$
—
CMS
Energy,
5.875%,
10/15/78
81,578
—
20,186
49,731
CMS
Energy,
5.875%,
3/1/79
111,396
—
34,878
61,510
Fortive
—
1,200,171
366,851
*
NiSource,
7.75%,
3/1/24
73,729
—
65,914
—
NiSource,
VR,
5.65%
45,986
—
24,456
*
NiSource,
Series
B,
VR,
6.50%
38,220
—
22,233
*
PerkinElmer
*
715,441
568,038
*
SCE
Trust
IV,
Series
J,
VR,
5.375%
49,999
—
8,946
29,636
T.
Rowe
Price
Institutional
Floating
Rate
Fund
–
Institutional
Class,
7.57%
617,662
174,200
—
749,303
TransUnion
*
847,955
4,208
576,044
T.
Rowe
Price
Government
Reserve
Fund,
4.30%
5,817,258
¤
¤
2,714,515
Total
$
4,180,739^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
+
Investment
income
comprised
$114,553
of
dividend
income
and
$2,266
of
interest
income.
*
On
the
date
indicated,
issuer
was
held
but
not
considered
an
affiliated
company.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$4,526,982.
T.
ROWE
PRICE
Capital
Appreciation
Fund
December
31,
2022
Statement
of
Assets
and
Liabilities
($000s,
except
shares
and
per
share
amounts)
Assets
Investments
in
securities,
at
value
(cost
$41,041,506)
$
45,648,915
Receivable
for
investment
securities
sold
201,133
Interest
and
dividends
receivable
147,360
Receivable
for
shares
sold
55,406
Foreign
currency
(cost
$2,617)
2,637
Cash
728
Other
assets
442
Total
assets
46,056,621
Liabilities
Payable
for
investment
securities
purchased
384,427
Payable
for
shares
redeemed
94,878
Options
written
(premiums
$240,046)
69,235
Investment
management
fees
payable
22,378
Due
to
affiliates
914
Payable
to
directors
29
Other
liabilities
28,739
Total
liabilities
600,600
NET
ASSETS
$
45,456,021
T.
ROWE
PRICE
Capital
Appreciation
Fund
December
31,
2022
Statement
of
Assets
and
Liabilities
($000s,
except
shares
and
per
share
amounts)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Net
Assets
Consist
of:
Total
distributable
earnings
(loss)
$
4,567,433
Paid-in
capital
applicable
to
1,529,417,374
shares
of
$0.0001
par
value
capital
stock
outstanding;
4,000,000,000
shares
authorized
40,888,588
NET
ASSETS
$
45,456,021
NET
ASSET
VALUE
PER
SHARE
Investor
Class
($26,104,068,719
/
877,966,400
shares
outstanding)
$
29.73
Advisor
Class
($654,436,752
/
22,333,527
shares
outstanding)
$
29.30
I
Class
($18,697,515,555
/
629,117,447
shares
outstanding)
$
29.72
T.
ROWE
PRICE
Capital
Appreciation
Fund
Year
Ended
12/31/22
Investment
Income
(Loss)
Income
Interest
$
637,725
Dividend
(net
of
foreign
taxes
of
$2,735)
426,154
Other
26
Total
income
1,063,905
Expenses
Investment
management
284,018
Shareholder
servicing
Investor
Class
$
40,887
Advisor
Class
1,078
I
Class
1,797
43,762
Rule
12b-1
fees
Advisor
Class
1,710
Prospectus
and
shareholder
reports
Investor
Class
848
Advisor
Class
6
I
Class
260
1,114
Custody
and
accounting
998
Registration
792
Directors
125
Legal
and
audit
47
Miscellaneous
187
Waived
/
paid
by
Price
Associates
(
10,255
)
Total
expenses
322,498
Net
investment
income
741,407
T.
ROWE
PRICE
Capital
Appreciation
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Year
Ended
12/31/22
Realized
and
Unrealized
Gain
/
Loss
–
Net
realized
gain
(loss)
Securities
3,150,369
Options
written
130,060
Foreign
currency
transactions
(
709
)
Net
realized
gain
3,279,720
Change
in
net
unrealized
gain
/
loss
Securities
(
11,110,566
)
Options
written
652,129
Other
assets
and
liabilities
denominated
in
foreign
currencies
33
Change
in
net
unrealized
gain
/
loss
(
10,458,404
)
Net
realized
and
unrealized
gain
/
loss
(
7,178,684
)
DECREASE
IN
NET
ASSETS
FROM
OPERATIONS
$
(
6,437,277
)
T.
ROWE
PRICE
Capital
Appreciation
Fund
Statement
of
Changes
in
Net
Assets
Year
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Ended
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
12/31/22
12/31/21
Increase
(Decrease)
in
Net
Assets
Operations
Net
investment
income
$
741,407
$
483,934
Net
realized
gain
3,279,720
3,835,909
Change
in
net
unrealized
gain
/
loss
(
10,458,404
)
4,098,382
Increase
(decrease)
in
net
assets
from
operations
(
6,437,277
)
8,418,225
Distributions
to
shareholders
Net
earnings
Investor
Class
(
2,278,489
)
(
3,438,345
)
Advisor
Class
(
55,813
)
(
66,905
)
I
Class
(
1,680,332
)
(
1,086,206
)
Decrease
in
net
assets
from
distributions
(
4,014,634
)
(
4,591,456
)
Capital
share
transactions
*
Shares
sold
Investor
Class
3,945,710
4,539,790
Advisor
Class
84,849
81,381
I
Class
10,858,872
3,387,930
Distributions
reinvested
Investor
Class
2,218,918
3,323,178
Advisor
Class
54,969
66,028
I
Class
1,617,001
1,055,820
Shares
redeemed
Investor
Class
(
13,844,290
)
(
5,665,745
)
Advisor
Class
(
129,121
)
(
187,752
)
I
Class
(
2,807,670
)
(
1,442,667
)
Increase
in
net
assets
from
capital
share
transactions
1,999,238
5,157,963
T.
ROWE
PRICE
Capital
Appreciation
Fund
Statement
of
Changes
in
Net
Assets
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Year
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Ended
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
12/31/22
12/31/21
Net
Assets
Increase
(decrease)
during
period
(
8,452,673
)
8,984,732
Beginning
of
period
53,908,694
44,923,962
End
of
period
$
45,456,021
$
53,908,694
*Share
information
(000s)
Shares
sold
Investor
Class
117,469
122,654
Advisor
Class
2,604
2,241
I
Class
318,283
91,171
Distributions
reinvested
Investor
Class
74,862
91,522
Advisor
Class
1,882
1,842
I
Class
54,573
29,062
Shares
redeemed
Investor
Class
(
408,978
)
(
153,176
)
Advisor
Class
(
3,921
)
(
5,155
)
I
Class
(
85,819
)
(
38,913
)
Increase
in
shares
outstanding
70,955
141,248
T.
ROWE
PRICE
Capital
Appreciation
Fund
NOTES
TO
FINANCIAL
STATEMENTS
T.
Rowe
Price
Capital
Appreciation
Fund,
Inc.
(the
fund) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act)
as a
diversified,
open-end
management
investment
company. The
fund
seeks
long-term
capital
appreciation
by
investing
primarily
in
common
stocks.
It
may
also
hold
fixed-income
and
other
securities
to
help
preserve
principal
value.
The
fund
has
three classes
of
shares:
the
Capital
Appreciation
Fund
(Investor
Class),
the
Capital
Appreciation
Fund–Advisor
Class
(Advisor
Class),
and
the
Capital
Appreciation
Fund–I
Class
(I
Class).
Advisor
Class
shares
are
sold
only
through
various
brokers
and
other
financial
intermediaries.
I
Class
shares
require
a
$500,000
initial
investment
minimum,
although
the
minimum
generally
is
waived
or
reduced
for
financial
intermediaries,
eligible
retirement
plans,
and
certain
other
accounts.
Prior
to
November
15,
2021,
the
initial
investment
minimum
was
$1
million
and
was
generally
waived
for
financial
intermediaries,
eligible
retirement
plans,
and
other
certain
accounts.
As
a
result
of
the
reduction
in
the
I
Class
minimum,
certain
assets
transferred
from
the
Investor
Class
to
the
I
Class.
This
transfer
of
shares
from
Investor
Class
to
I
Class
is
reflected
in
the
Statement
of
Changes
in
Net
Assets
within
the
Capital
shares
transactions
as
Shares
redeemed
and
Shares
sold,
respectively.
The
Advisor
Class
operates
under
a
Board-approved
Rule
12b-1
plan
pursuant
to
which
the
class
compensates
financial
intermediaries
for
distribution,
shareholder
servicing,
and/
or
certain
administrative
services;
the
Investor
and
I
Classes
do
not
pay
Rule
12b-1
fees. Each
class
has
exclusive
voting
rights
on
matters
related
solely
to
that
class;
separate
voting
rights
on
matters
that
relate
to
all
classes;
and,
in
all
other
respects,
the
same
rights
and
obligations
as
the
other
classes.
NOTE
1
-
SIGNIFICANT
ACCOUNTING
POLICIES
Basis
of
Preparation
The fund
is
an
investment
company
and
follows
accounting
and
reporting
guidance
in
the
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946
(ASC
946).
The
accompanying
financial
statements
were
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP),
including,
but
not
limited
to,
ASC
946.
GAAP
requires
the
use
of
estimates
made
by
management.
Management
believes
that
estimates
and
valuations
are
appropriate;
however,
actual
results
may
differ
from
those
estimates,
and
the
valuations
reflected
in
the
accompanying
financial
statements
may
differ
from
the
value
ultimately
realized
upon
sale
or
maturity.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Investment
Transactions,
Investment
Income,
and
Distributions
Investment
transactions
are
accounted
for
on
the
trade
date
basis.
Income
and
expenses
are
recorded
on
the
accrual
basis.
Realized
gains
and
losses
are
reported
on
the
identified
cost
basis.
Premiums
and
discounts
on
debt
securities
are
amortized
for
financial
reporting
purposes.
Paydown
gains
and
losses
are
recorded
as
an
adjustment
to
interest
income.
Income
tax-related
interest
and
penalties,
if
incurred,
are
recorded
as
income
tax
expense.
Dividends
received
from
mutual
fund
investments
are
reflected
as
dividend
income;
capital
gain
distributions
are
reflected
as
realized
gain/loss.
Dividend
income
and
capital
gain
distributions
are
recorded
on
the
ex-dividend
date.
Non-cash
dividends,
if
any,
are
recorded
at
the
fair
market
value
of
the
asset
received.
Proceeds
from
litigation
payments,
if
any,
are
included
in
either
net
realized
gain
(loss)
or
change
in
net
unrealized
gain/loss
from
securities.
Distributions
to
shareholders
are
recorded
on
the
ex-dividend
date.
Income
distributions,
if
any,
are
declared
and
paid
by
each
class annually.
A
capital
gain
distribution,
if
any, may
also
be
declared
and
paid
by
the
fund
annually.
Currency
Translation
Assets,
including
investments,
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Purchases
and
sales
of
securities,
income,
and
expenses
are
translated
into
U.S.
dollars
at
the
prevailing
exchange
rate
on
the
respective
date
of
such
transaction.
The
effect
of
changes
in
foreign
currency
exchange
rates
on
realized
and
unrealized
security
gains
and
losses
is
not
bifurcated
from
the
portion
attributable
to
changes
in
market
prices.
Class
Accounting
Shareholder
servicing,
prospectus,
and
shareholder
report
expenses
incurred
by
each
class
are
charged
directly
to
the
class
to
which
they
relate.
Expenses
common
to all classes,
investment
income,
and
realized
and
unrealized
gains
and
losses
are
allocated
to
the
classes
based
upon
the
relative
daily
net
assets
of
each
class.
The
Advisor
Class
pays
Rule
12b-1
fees,
in
an
amount
not
exceeding
0.25%
of
the
class’s
average
daily
net
assets.
Capital
Transactions
Each
investor’s
interest
in
the
net
assets
of the
fund
is
represented
by
fund
shares. The
fund’s
net
asset
value
(NAV)
per
share
is
computed
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business.
However,
the
NAV
per
share
may
be
calculated
at
a
time
other
than
the
normal
close
of
the
NYSE
if
trading
on
the
NYSE
is
restricted,
if
the
NYSE
closes
earlier,
or
as
may
be
permitted
by
the
SEC.
Purchases
and
redemptions
of
fund
shares
are
transacted
at
the
next-computed
NAV
per
share,
after
receipt
of
the
transaction
order
by
T.
Rowe
Price
Associates,
Inc.,
or
its
agents.
T.
ROWE
PRICE
Capital
Appreciation
Fund
New
Accounting
Guidance
In
June
2022,
the
FASB
issued
Accounting
Standards
Update
(ASU),
ASU
2022-03,
Fair
Value
Measurement
(Topic
820)
–
Fair
Value
Measurement
of
Equity
Securities
Subject
to
Contractual
Sale
Restrictions,
which
clarifies
that
a
contractual
restriction
on
the
sale
of
an
equity
security
is
not
considered
part
of
the
unit
of
account
of
the
equity
security
and,
therefore,
is
not
considered
in
measuring
fair
value.
The
amendments
under
this
ASU
are
effective
for
fiscal
years
beginning
after
December
15,
2023;
however,
the
fund
opted
to
early
adopt,
as
permitted,
effective
December
1,
2022. Adoption
of
the
guidance
did not
have
a
material
impact
on
the fund's
financial statements.
The
FASB
issued
Accounting
Standards
Update
(ASU),
ASU
2020–04,
Reference
Rate
Reform
(Topic
848) –
Facilitation
of
the
Effects
of
Reference
Rate
Reform
on
Financial
Reporting
in
March
2020
and
ASU
2021-01
in
January
2021
which
provided
further
amendments
and
clarifications
to
Topic
848.
These
ASUs provide
optional,
temporary
relief
with
respect
to
the
financial
reporting
of
contracts
subject
to
certain
types
of
modifications
due
to
the
planned
discontinuation
of
the
London
Interbank
Offered
Rate
(LIBOR),
and
other
interbank-offered
based
reference
rates,
through December
31,
2022.
In
December,
2022,
FASB
issued
ASU
2022-06
which
defers
the
sunset
date
of
Topic
848
from
December
31,
2022,
to
December
31,
2024,
after
which
entities
will
no
longer
be
permitted
to
apply
the
relief
in
Topic
848.
Management
intends
to
rely
upon
the
relief
provided
under
Topic
848,
which
is
not
expected to
have
a
material
impact
on
the fund's
financial statements.
Indemnification
In
the
normal
course
of
business, the
fund
may
provide
indemnification
in
connection
with
its
officers
and
directors,
service
providers,
and/or
private
company
investments. The
fund’s
maximum
exposure
under
these
arrangements
is
unknown;
however,
the
risk
of
material
loss
is
currently
considered
to
be
remote.
NOTE
2
-
VALUATION
Fair
Value
The
fund’s
financial
instruments
are
valued
at
the
close
of
the
NYSE
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
T.
ROWE
PRICE
Capital
Appreciation
Fund
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
–
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
–
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
–
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
T.
ROWE
PRICE
Capital
Appreciation
Fund
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the Valuation
Designee
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of the
fund’s
portfolio
securities.
Each
business
day,
the
Valuation
Designee uses
information
from
outside
pricing
services
to
evaluate
the
quoted
prices
of
portfolio
securities
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The Valuation
Designee
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The Valuation
Designee
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Debt
securities
generally
are
traded
in
the over-the-counter
(OTC)
market
and
are
valued
at
prices
furnished
by
independent
pricing
services
or
by
broker
dealers
who
make
markets
in
such
securities.
When
valuing
securities,
the
independent
pricing
services
consider
factors
such
as,
but
not
limited
to,
the
yield
or
price
of
bonds
of
comparable
quality,
coupon,
maturity,
and
type,
as
well
as
prices
quoted
by
dealers
who
make
markets
in
such
securities.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Listed
options,
and
OTC
options
with
a
listed
equivalent,
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
and
exchange-traded
options
on
futures
contracts
are
valued
at
closing
settlement
prices.
Assets
and
liabilities
other
than
financial
instruments,
including
short-term
receivables
and
payables,
are
carried
at
cost,
or
estimated
realizable
value,
if
less,
which
approximates
fair
value.
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
T.
ROWE
PRICE
Capital
Appreciation
Fund
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
Valuation
Inputs
The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
December
31,
2022
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
NOTE
3
-
DERIVATIVE
INSTRUMENTS
During
the
year ended
December
31,
2022,
the
fund
invested
in
derivative
instruments.
As
defined
by
GAAP,
a
derivative
is
a
financial
instrument
whose
value
is
derived
from
an
underlying
security
price,
foreign
exchange
rate,
interest
rate,
index
of
prices
or
rates,
or
other
variable;
it
requires
little
or
no
initial
investment
and
permits
or
requires
net
settlement.
The
fund
invests
in
derivatives
only
if
the
expected
risks
and
rewards
are
consistent
with
its
investment
objectives,
policies,
and
overall
risk
profile,
as
described
in
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Fixed
Income
Securities
1
$
—
$
10,057,442
$
—
$
10,057,442
Bond
Mutual
Funds
749,303
—
—
749,303
Common
Stocks
27,658,896
477,937
—
28,136,833
Convertible
Preferred
Stocks
—
—
109,432
109,432
Corporate
Bonds
—
3,725,748
—
3,725,748
Preferred
Stocks
155,642
—
—
155,642
Short-Term
Investments
2,714,515
—
—
2,714,515
Total
$
31,278,356
$
14,261,127
$
109,432
$
45,648,915
Liabilities
Options
Written
$
—
$
69,235
$
—
$
69,235
1
Includes
Asset-Backed
Securities,
Bank
Loans,
Convertible
Bonds
and
U.S.
Government
Agency
Obligations
(Excluding
Mortgage-Backed).
T.
ROWE
PRICE
Capital
Appreciation
Fund
its
prospectus
and
Statement
of
Additional
Information.
The
fund
may
use
derivatives
for
a
variety
of
purposes
and
may
use
them
to
establish
both
long
and
short
positions
within
the
fund’s
portfolio.
Potential
uses
include
to
hedge
against
declines
in
principal
value,
increase
yield,
invest
in
an
asset
with
greater
efficiency
and
at
a
lower
cost
than
is
possible
through
direct
investment,
to
enhance
return,
or
to
adjust
credit
exposure.
The
risks
associated
with
the
use
of
derivatives
are
different
from,
and
potentially
much
greater
than,
the
risks
associated
with
investing
directly
in
the
instruments
on
which
the
derivatives
are
based.
The
fund
values
its
derivatives
at
fair
value
and
recognizes
changes
in
fair
value
currently
in
its
results
of
operations.
Accordingly,
the
fund
does
not
follow
hedge
accounting,
even
for
derivatives
employed
as
economic
hedges.
Generally,
the
fund
accounts
for
its
derivatives
on
a
gross
basis.
It
does
not
offset
the
fair
value
of
derivative
liabilities
against
the
fair
value
of
derivative
assets
on
its
financial
statements,
nor
does
it
offset
the
fair
value
of
derivative
instruments
against
the
right
to
reclaim
or
obligation
to
return
collateral.
The
following
table
summarizes
the
fair
value
of
the
fund’s
derivative
instruments
held
as
of
December
31,
2022,
and
the
related
location
on
the
accompanying
Statement
of
Assets
and
Liabilities,
presented
by
primary
underlying
risk
exposure:
($000s)
Location
on
Statement
of
Assets
and
Liabilities
Fair
Value
Liabilities
Equity
derivatives
Options
Written
$
69,235
Total
$
69,235
T.
ROWE
PRICE
Capital
Appreciation
Fund
Additionally,
the
amount
of
gains
and
losses
on
derivative
instruments
recognized
in
fund
earnings
during
the
year ended
December
31,
2022,
and
the
related
location
on
the
accompanying
Statement
of
Operations
is
summarized
in
the
following
table
by
primary
underlying
risk
exposure:
Counterparty
Risk
and
Collateral
The
fund
invests
in
derivatives,
such
as
non-cleared
bilateral
swaps,
forward
currency
exchange
contracts,
and/or
OTC
options,
that
are
transacted
and
settle
directly
with
a
counterparty
(bilateral
derivatives),
and
thereby
may
expose
the
fund
to
counterparty
risk.
To
mitigate
this
risk,
the
fund
has
entered
into
master
netting
arrangements
(MNAs)
with
certain
counterparties
that
permit
net
settlement
under
specified
conditions
and,
for
certain
counterparties,
also
require
the
exchange
of
collateral
to
cover
mark-to-market
exposure.
MNAs
may
be
in
the
form
of
International
Swaps
and
Derivatives
Association
master
agreements
(ISDAs)
or
foreign
exchange
letter
agreements
(FX
letters).
MNAs
govern
the
ability
to
offset
amounts
the
fund
owes
a
counterparty
against
amounts
the
counterparty
owes
the
fund
(net
settlement).
Both
ISDAs
and
FX
letters
generally
allow
termination
of
transactions
and
net
settlement
upon
the
occurrence
of
contractually
specified
events,
such
as
failure
to
pay
or
bankruptcy.
In
addition,
ISDAs
specify
other
events,
the
occurrence
of
which
would
allow
one
of
the
parties
to
terminate.
For
example,
a
downgrade
in
credit
rating
of
a
counterparty
below
a
specified
rating
would
allow
the
fund
to
terminate,
while
a
decline
in
the
fund’s
net
assets
of
more
than
a
specified
percentage
would
allow
the
counterparty
to
terminate.
Upon
termination,
all
transactions
with
that
counterparty
would
be
liquidated
and
a
net
termination
amount
determined.
ISDAs
typically
include
collateral
agreements
($000s)
Location
of
Gain
(Loss)
on
Statement
of
Operations
Options
Written
Realized
Gain
(Loss)
Equity
derivatives
$
130,060
Total
$
130,060
Change
in
Unrealized
Gain
(Loss)
Equity
derivatives
$
652,129
Total
$
652,129
T.
ROWE
PRICE
Capital
Appreciation
Fund
whereas
FX
letters
do
not.
Collateral
requirements
are
determined
daily
based
on
the
net
aggregate
unrealized
gain
or
loss
on
all
bilateral
derivatives
with
each
counterparty,
subject
to
minimum
transfer
amounts
that
typically
range
from
$100,000
to
$250,000.
Any
additional
collateral
required
due
to
changes
in
security
values
is
typically
transferred
the
next
business
day.
Collateral may
be
in
the
form
of
cash
or
debt
securities
issued
by
the
U.S.
government
or
related
agencies,
although
other
securities
may
be
used
depending
on
the
terms
outlined
in
the
applicable
MNA.
Cash
posted
by
the
fund
is
reflected
as
cash
deposits
in
the
accompanying
financial
statements
and
generally
is
restricted
from
withdrawal
by
the
fund;
securities
posted
by
the
fund
are
so
noted
in
the
accompanying
Portfolio
of
Investments;
both
remain
in
the
fund’s
assets.
Collateral
pledged
by
counterparties
is
not
included
in
the
fund’s
assets
because
the
fund
does
not
obtain
effective
control
over
those
assets.
For
bilateral
derivatives,
collateral
posted
or
received
by
the
fund
is
held
in
a
segregated
account
at
the
fund’s
custodian.
While
typically
not
sold
in
the
same
manner
as
equity
or
fixed
income
securities,
OTC
and
bilateral
derivatives
may
be
unwound
with
counterparties
or
transactions
assigned
to
other
counterparties
to
allow
the
fund
to
exit
the
transaction.
This
ability
is
subject
to
the
liquidity
of
underlying
positions. As
of
December
31,
2022,
securities
valued
at $1,411,952,000
had
been
posted
by
the
fund
to
counterparties
for
bilateral
derivatives. As
of
December
31,
2022,
no
collateral
was
pledged
by
counterparties
to
the
fund
for
bilateral
derivatives.
Options
The
fund
is
subject
to equity
price
risk in
the
normal
course
of
pursuing
its
investment
objectives
and
uses
options
to
help
manage
such
risk.
The
fund
may
use
options
to
manage
exposure
to
security
prices,
interest
rates,
foreign
currencies,
and
credit
quality;
as
an
efficient
means
of
adjusting
exposure
to
all
or
a
part
of
a
target
market;
to
enhance
income;
as
a
cash
management
tool;
or
to
adjust
credit
exposure.
Options
are
included
in
net
assets
at
fair
value,
options
purchased
are
included
in
Investments
in
Securities,
and
options
written
are
separately
reflected
as
a
liability
on
the
accompanying
Statement
of
Assets
and
Liabilities.
Premiums
on
unexercised,
expired
options
are
recorded
as
realized
gains
or
losses;
premiums
on
exercised
options
are
recorded
as
an
adjustment
to
the
proceeds
from
the
sale
or
cost
of
the
purchase.
The
difference
between
the
premium
and
the
amount
received
or
paid
in
a
closing
transaction
is
also
treated
as
realized
gain
or
loss.
In
return
for
a
premium
paid,
call
and
put
options
give
the
holder
the
right,
but
not
the
obligation,
to
purchase
or
sell,
respectively,
a
security
at
a
specified
exercise
price.
Risks related
to
the
use
of
options
include
possible
illiquidity
of
the
options
markets;
trading
restrictions
imposed
by
an
exchange
or
counterparty;
possible
failure
of
counterparties
to
meet
the
terms
of
the
agreements;
movements
in
the
underlying
asset
values
and,
for
options
written,
the
T.
ROWE
PRICE
Capital
Appreciation
Fund
potential
for
losses
to
exceed
any
premium
received
by
the
fund.
During
the
year ended
December
31,
2022,
the
volume
of
the
fund’s
activity
in
options,
based
on
underlying
notional
amounts,
was
generally
between
6%
and
13%
of
net
assets.
NOTE
4
-
OTHER
INVESTMENT
TRANSACTIONS
Consistent
with
its
investment
objective,
the
fund
engages
in
the
following
practices
to
manage
exposure
to
certain
risks
and/or
to
enhance
performance.
The
investment
objective,
policies,
program,
and
risk
factors
of
the
fund
are
described
more
fully
in
the
fund’s
prospectus
and
Statement
of
Additional
Information.
Noninvestment-Grade
Debt
The
fund
invests,
either
directly
or
through
its
investment
in
other
T.
Rowe
Price
funds,
in
noninvestment-grade
debt,
including
“high
yield”
or
“junk”
bonds
or
leveraged
loans.
Noninvestment-grade
debt
issuers
are
more
likely
to
suffer
an
adverse
change
in
financial
condition
that
would
result
in
the
inability
to
meet
a
financial
obligation.
The
noninvestment-grade
debt
market
may
experience
sudden
and
sharp
price
swings
due
to
a
variety
of
factors
that
may
decrease
the
ability
of
issuers
to
make
principal
and
interest
payments
and
adversely
affect
the
liquidity
or
value,
or
both,
of
such
securities.
Accordingly,
securities
issued
by
such
companies
carry
a
higher
risk
of
default
and
should
be
considered
speculative.
Restricted
Securities
The
fund
invests
in
securities
that
are
subject
to
legal
or
contractual
restrictions
on
resale.
Prompt
sale
of
such
securities
at
an
acceptable
price
may
be
difficult
and
may
involve
substantial
delays
and
additional
costs.
When-Issued
Securities
The fund
enters
into
when-issued
purchase
or
sale
commitments,
pursuant
to
which
it
agrees
to
purchase
or
sell,
respectively,
an
authorized
but
not
yet
issued
security
for
a
fixed
unit
price,
with
payment
and
delivery
not
due
until
issuance
of
the
security
on
a
scheduled
future
date.
When-issued
securities
may
be
new
securities
or
securities
issued
through
a
corporate
action,
such
as
a
reorganization
or
restructuring.
Until
settlement,
the
fund
maintains
liquid
assets
sufficient
to
settle
its
commitment
to
purchase
a
when-issued
security
or,
in
the
case
of
a
sale
commitment,
the
fund
maintains
an
entitlement
to
the
security
to
be
sold.
Amounts
realized
on
when-
issued
transactions
are
included
in
realized
gain/loss
on
securities
in
the
accompanying
financial
statements.
Bank
Loans
The
fund
invests
in
bank
loans,
which
represent
an
interest
in
amounts
owed
by
a
borrower
to
a
syndicate
of
lenders.
Bank
loans
are
generally
noninvestment
grade
and
often
involve
borrowers
whose
financial
condition
is
highly
leveraged.
The
fund
may
invest
in
fixed
and
floating
rate
loans,
which
may
include
senior
floating
rate
loans;
secured
and
unsecured
loans,
second
lien
or
more
junior
loans;
and
bridge
loans
T.
ROWE
PRICE
Capital
Appreciation
Fund
or
bridge
facilities.
Certain
bank
loans
may
be
revolvers
which
are
a
form
of
senior
bank
debt,
where
the
borrower
can
draw
down
the
credit
of
the
revolver
when
it
needs
cash
and
repays
the
credit
when
the
borrower
has
excess
cash.
Certain
loans
may
be
“covenant-lite”
loans,
which
means
the
loans
contain
fewer
maintenance
covenants
than
other
loans
(in
some
cases,
none)
and
do
not
include
terms
which
allow
the
lender
to
monitor
the
performance
of
the
borrower
and
declare
a
default
if
certain
criteria
are
breached.
As
a
result
of
these
risks,
the
fund’s
exposure
to
losses
may
be
increased.
Bank
loans
may
be
in
the
form
of
either
assignments
or
participations.
A
loan
assignment
transfers
all
legal,
beneficial,
and
economic
rights
to
the
buyer,
and
transfer
typically
requires
consent
of
both
the
borrower
and
agent.
In
contrast,
a
loan
participation
generally
entitles
the
buyer
to
receive
the
cash
flows
from
principal,
interest,
and
any
fee
payments
on
a
portion
of
a
loan;
however,
the
seller
continues
to
hold
legal
title
to
that
portion
of
the
loan.
As
a
result,
the
buyer
of
a
loan
participation
generally
has
no
direct
recourse
against
the
borrower
and
is
exposed
to
credit
risk
of
both
the
borrower
and
seller
of
the
participation.
Bank
loans
often
have
extended
settlement
periods,
generally
may
be
repaid
at
any
time
at
the
option
of
the
borrower,
and
may
require
additional
principal
to
be
funded
at
the
borrowers’
discretion
at
a
later
date
(e.g.
unfunded
commitments
and
revolving
debt
instruments).
Until
settlement,
the
fund
maintains
liquid
assets
sufficient
to
settle
its
unfunded
loan
commitments.
The
fund
reflects
both
the
funded
portion
of
a
bank
loan
as
well
as
its
unfunded
commitment
in
the
Portfolio
of
Investments.
However,
if
a
credit
agreement
provides
no
initial
funding
of
a
tranche,
and
funding
of
the
full
commitment
at
a
future
date(s)
is
at
the
borrower’s
discretion
and
considered
uncertain,
a
loan
is
reflected
in
the
Portfolio
of
Investments
only
if,
and
only
to
the
extent
that,
the
fund
has
actually
settled
a
funding
commitment.
LIBOR
Transition
The fund
may
invest
in
instruments
that
are
tied
to
reference
rates,
including
LIBOR.
Over
the
course
of
the
last
several
years,
global
regulators
have
indicated
an
intent
to
phase
out
the
use
of
LIBOR
and
similar
interbank
offered
rates
(IBOR).
While
publication
for
most
LIBOR
currencies
and
lesser-used
USD
LIBOR
settings
ceased
immediately
after
December
31,
2021,
remaining
USD
LIBOR
settings
will
continue
to
be
published
until
June
30,
2023.
There
remains
uncertainty
regarding
the
future
utilization
of
LIBOR
and
the
nature
of
any
replacement
rate.
Any
potential
effects
of
the
transition
away
from
LIBOR
on
the fund,
or
on
certain
instruments
in
which
the fund
invests,
cannot
yet
be
determined.
The
transition
process
may
result
in,
among
other
things,
an
increase
in
volatility
or
illiquidity
of
markets
for
instruments
that
currently
rely
on
LIBOR,
a
reduction
in
the
value
of
certain
instruments
held
by
the fund,
or
a
reduction
in
the
effectiveness
of
related
fund
transactions
such
as
hedges.
Any
such
effects
could
have
an
adverse
impact
on
the fund's
performance.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Other
Purchases
and
sales
of
portfolio
securities
other
than
short-term and
U.S.
government
securities
aggregated $30,506,654,000 and
$33,410,639,000,
respectively,
for
the
year ended
December
31,
2022.
Purchases
and
sales
of
U.S.
government
securities
aggregated
$9,314,967,000 and
$4,921,958,000,
respectively,
for
the
year ended
December
31,
2022.
NOTE
5
-
FEDERAL
INCOME
TAXES
Generally,
no
provision
for
federal
income
taxes
is
required
since
the
fund
intends
to
continue
to
qualify
as
a
regulated
investment
company
under
Subchapter
M
of
the
Internal
Revenue
Code
and
distribute
to
shareholders
all
of
its
taxable
income
and
gains.
Distributions
determined
in
accordance
with
federal
income
tax
regulations
may
differ
in
amount
or
character
from
net
investment
income
and
realized
gains
for
financial
reporting
purposes.
The fund
files
U.S.
federal,
state,
and
local
tax
returns
as
required. The
fund’s
tax
returns
are
subject
to
examination
by
the
relevant
tax
authorities
until
expiration
of
the
applicable
statute
of
limitations,
which
is
generally
three
years
after
the
filing
of
the
tax
return
but
which
can
be
extended
to
six
years
in
certain
circumstances.
Tax
returns
for
open
years
have
incorporated
no
uncertain
tax
positions
that
require
a
provision
for
income
taxes.
Capital
accounts
within
the
financial
reporting
records
are
adjusted
for
permanent
book/
tax
differences
to
reflect
tax
character
but
are
not
adjusted
for
temporary
differences.
The
permanent
book/tax
adjustments,
if
any,
have
no
impact
on
results
of
operations
or
net
assets.
The
permanent
book/tax
adjustments
relate
primarily
to
deemed
distributions
on
shareholder
redemptions.
The
tax
character
of
distributions
paid
for
the
periods
presented
was
as
follows:
($000s)
December
31,
2022
December
31,
2021
Ordinary
income
(including
short-term
capital
gains,
if
any)
$
727,424
$
2,335,918
Long-term
capital
gain
3,287,210
2,255,538
Total
distributions
$
4,014,634
$
4,591,456
T.
ROWE
PRICE
Capital
Appreciation
Fund
At
December
31,
2022,
the
tax-basis
cost
of
investments
(including
derivatives,
if
any)
and
gross
unrealized
appreciation
and
depreciation
were
as
follows:
At
December
31,
2022,
the
tax-basis
components
of
accumulated
net
earnings
(loss)
were
as
follows:
Temporary
differences
between
book-basis
and
tax-basis
components
of
total
distributable
earnings
(loss)
arise
when
certain
items
of
income,
gain,
or
loss
are
recognized
in
different
periods
for
financial
statement
purposes
versus
for
tax
purposes;
these
differences
will
reverse
in
a
subsequent
reporting
period.
The
temporary
differences
relate
primarily
to
the
deferral
of
losses
from
wash
sales.
NOTE
6
-
FOREIGN TAXES
The
fund
is
subject
to
foreign
income
taxes
imposed
by
certain
countries
in
which
it
invests.
Additionally,
capital
gains
realized
upon
disposition
of
securities
issued
in
or
by
certain
foreign
countries
are
subject
to
capital
gains
tax
imposed
by
those
countries.
All
taxes
are
computed
in
accordance
with
the
applicable
foreign
tax
law,
and,
to
the
extent
permitted,
capital
losses
are
used
to
offset
capital
gains.
Taxes
attributable
to
income
are
accrued
by
the
fund
as
a
reduction
of
income.
Current
and
deferred
tax
expense
attributable
to
capital
gains
is
reflected
as
a
component
of
realized
or
change
in
unrealized
gain/loss
on
securities
in
the
accompanying
financial
statements.
To
the
extent
that
the
fund
has
country
specific
capital
loss
carryforwards,
such
carryforwards
are
applied
against
net
unrealized
gains
when
determining
the
deferred
tax
liability.
Any
deferred
tax
liability
incurred
by
the
fund
is
included
in
either
Other
liabilities
or
Deferred
tax
liability
on
the
accompanying
Statement
of
Assets
and
Liabilities.
($000s)
Cost
of
investments
$
41,189,632
Unrealized
appreciation
$
6,568,074
Unrealized
depreciation
(2,177,994)
Net
unrealized
appreciation
(depreciation)
$
4,390,080
($000s)
Undistributed
long-term
capital
gain
$
177,353
Net
unrealized
appreciation
(depreciation)
4,390,080
Total
distributable
earnings
(loss)
$
4,567,433
T.
ROWE
PRICE
Capital
Appreciation
Fund
NOTE
7
-
RELATED
PARTY
TRANSACTIONS
The
fund
is
managed
by
T.
Rowe
Price
Associates,
Inc.
(Price
Associates),
a
wholly
owned
subsidiary
of
T.
Rowe
Price
Group,
Inc.
(Price
Group). Price
Associates
has
entered
into
a
sub-advisory
agreement(s)
with
one
or
more
of
its
wholly
owned
subsidiaries,
to
provide
investment
advisory
services
to
the
fund. The
investment
management
agreement
between
the
fund
and
Price
Associates
provides
for
an
annual
investment
management
fee
that
consists
of
an
individual
fund
fee
and
a
group
fee;
management
fees
are
computed
daily
and
paid
monthly.
The
investment
management
agreement
provides
for
an
individual
fund
fee
equal
to
0.30%
of
the fund’s
average
daily
net
assets.
The
group
fee
rate
is
calculated
based
on
the
combined
net
assets
of
certain
mutual
funds
sponsored
by
Price
Associates
(the
group)
applied
to
a
graduated
fee
schedule,
with
rates
ranging
from
0.48%
for
the
first
$1
billion
of
assets
to
0.260%
for
assets
in
excess
of
$845
billion.
The
fund’s
group
fee
is
determined
by
applying
the
group
fee
rate
to
the
fund’s
average
daily
net
assets.
At December
31,
2022,
the
effective
annual
group
fee
rate
was
0.29%. Effective
April
30,
2019,
Price
Associates
has
contractually
agreed,
at
least
through
April
30,
2023,
to
waive
a
portion
of
its
management
fee
so
that
an
individual
fund
fee
of 0.27%
is
applied
to
the
fund’s
average
daily
net
assets
that
are
equal
to
or
greater
than $27.5
billion.
Thereafter,
this
agreement
will
automatically
renew
for
one-year
terms
unless
terminated
by
the
fund’s
Board.
Any
fees
waived
under
this
agreement
are
not
subject
to
reimbursement
to
Price
Associates
by
the
fund. The
total
management
fees
waived
were $6,311,000
and
allocated
ratably
in
the
amounts
of
$3,867,000
for
the
Investor
Class,
$90,000
for
the
Advisor
Class,
and
$2,354,000
for
the
I
Class,
for
the
year
ended
December
31,
2022.
The
I
Class
is
subject
to
an
operating
expense
limitation
(I
Class
Limit)
pursuant
to
which
Price
Associates
is
contractually
required
to
pay
all
operating
expenses
of
the
I
Class,
excluding
management
fees;
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage; non-recurring,
extraordinary expenses; and
acquired
fund
fees
and
expenses, to
the
extent
such
operating
expenses,
on
an
annualized
basis,
exceed
the
I
Class
Limit. This
agreement
will
continue
through
the
expense
limitation
date
indicated
in
the
table
below,
and
may
be
renewed,
revised,
or
revoked
only
with
approval
of
the
fund’s
Board.
The
I
Class
is
required
to
repay
Price
Associates
for
expenses
previously
paid
to
the
extent
the
class’s
net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the
class’s
operating
expenses
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
I
Class
Limit
in
place
at
the
time
such
amounts
were
paid;
or
(2)
the
current
I
Class
Limit.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
T.
ROWE
PRICE
Capital
Appreciation
Fund
In
addition,
the
fund
has
entered
into
service
agreements
with
Price
Associates
and
two
wholly
owned
subsidiaries
of
Price
Associates,
each
an
affiliate
of
the
fund
(collectively,
Price).
Price
Associates
provides
certain
accounting
and
administrative
services
to
the
fund.
T.
Rowe
Price
Services,
Inc.
provides
shareholder
and
administrative
services
in
its
capacity
as
the
fund’s
transfer
and
dividend-disbursing
agent.
T.
Rowe
Price
Retirement
Plan
Services,
Inc.
provides
subaccounting
and
recordkeeping
services
for
certain
retirement
accounts
invested
in
the
Investor
Class
and
Advisor Class.
For
the
year ended
December
31,
2022,
expenses
incurred
pursuant
to
these
service
agreements
were
$102,000 for
Price
Associates;
$7,953,000 for
T.
Rowe
Price
Services,
Inc.;
and
$1,434,000 for
T.
Rowe
Price
Retirement
Plan
Services,
Inc.
All
amounts
due
to
and
due
from
Price,
exclusive
of
investment
management
fees
payable,
are
presented
net
on
the
accompanying
Statement
of
Assets
and
Liabilities.
The fund
may
invest
its
cash
reserves
in
certain
open-end
management
investment
companies
managed
by
Price
Associates
and
considered
affiliates
of
the
fund:
the
T.
Rowe
Price
Government
Reserve
Fund
or
the
T.
Rowe
Price
Treasury
Reserve
Fund,
organized
as
money
market
funds
(together,
the
Price
Reserve
Funds).
The
Price
Reserve
Funds
are
offered
as
short-term
investment
options
to
mutual
funds,
trusts,
and
other
accounts
managed
by
Price
Associates
or
its
affiliates
and
are
not
available
for
direct
purchase
by
members
of
the
public.
Cash
collateral
from
securities
lending,
if
any,
is
invested
in
the
T.
Rowe
Price
Government
Reserve Fund. The
Price
Reserve
Funds
pay
no
investment
management
fees.
The
fund
may
also
invest
in
certain
other
T.
Rowe
Price
funds
(Price
Funds)
as
a
means
of
gaining
efficient
and
cost-effective
exposure
to
certain
markets.
The
fund
does
not
invest
for
the
purpose
of
exercising
management
or
control;
however,
investments
by
the
fund
may
represent
a
significant
portion
of
an
underlying
Price
Fund’s
net
assets.
Each
underlying
Price
Fund
is
an
open-end
management
investment
company
managed
by
Price
Associates
and
is
considered
an
affiliate
of
the
fund.
To
ensure
that
the
fund
does
not
incur
duplicate
management
fees
(paid
by
the
underlying
Price
Fund(s)
and
the
fund),
Price
Associates
has
agreed
to
permanently
waive
a
portion
of
its
management
fee
charged
to
the
fund
in
an
amount
sufficient
to
fully
offset
that
portion
of
management
I
Class
Expense
limitation/I
Class
Limit
0.05%
Expense
limitation
date
04/30/24
(Waived)/repaid
during
the
period
($000s)
$—
T.
ROWE
PRICE
Capital
Appreciation
Fund
fees
paid
by
each
underlying
Price
Fund
related
to
the
fund’s
investment
therein.
Annual
management
fee
rates
and
amounts
waived
related
to
investments
in
the
underlying
Price
Fund(s)
for
the
year
ended
December
31,
2022,
are
as
follows:
Total
management
fee
waived
was
allocated
ratably
in
the
amounts
of
$2,384,000,
$56,000
and
$1,504,000
for
the
Investor
Class,
Advisor
Class,
and
I
Class,
respectively,
for
the
year ended
December
31,
2022.
As
of
December
31,
2022,
T.
Rowe
Price
Group,
Inc.,
or
its
wholly
owned
subsidiaries,
owned
2,548,278
shares
of
the
Investor
Class,
representing
less
than
1%
of
the
Investor
Class's
net
assets,
and
3,405,025
shares
of
the
I
Class,
representing
less
than
1%
of
the
I
Class's
net
assets.
The
fund may
participate
in
securities
purchase
and
sale
transactions
with
other
funds
or
accounts
advised
by
Price
Associates
(cross
trades),
in
accordance
with
procedures
adopted
by the
fund’s
Board
and
Securities
and
Exchange
Commission
rules,
which
require,
among
other
things,
that
such
purchase
and
sale
cross
trades
be
effected
at
the
independent
current
market
price
of
the
security.
During
the
year ended
December
31,
2022,
the
fund
had
no
purchases
or
sales
cross
trades
with
other
funds
or
accounts
advised
by
Price
Associates.
Price
Associates
has
voluntarily
agreed
to
reimburse
the
fund
from
its
own
resources
on
a
monthly
basis
for
the
cost
of
investment
research
embedded
in
the
cost
of
the
fund’s
securities
trades
and
for
the
cost
of
brokerage
commissions
embedded
in
the
cost
of
the
fund’s
foreign
currency
transactions.
These
agreements
may
be
rescinded
at
any
time.
For
the
year ended
December
31,
2022,
these
reimbursements
amounted
to
$2,131,000,
which
is
included
in
Net
realized
gain
(loss)
on
Securities
in
the
Statement
of
Operations.
($000s)
Effective
Management
Fee
Rate
Management
Fee
Waived
T.
Rowe
Price
Institutional
Floating
Rate
Fund
–
Institutional
Class
0.55%
$
3,944
Total
Management
Fee
Waived
$
3,944
T.
ROWE
PRICE
Capital
Appreciation
Fund
NOTE
8
-
OTHER
MATTERS
Unpredictable
events
such
as
environmental
or
natural
disasters,
war,
terrorism,
pandemics,
outbreaks
of
infectious
diseases,
and
similar
public
health
threats
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
the fund
invests.
Certain
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-existing
political,
social,
and
economic
risks.
Since
2020,
a
novel
strain
of
coronavirus
(COVID-19)
has
resulted
in
disruptions
to
global
business
activity
and
caused
significant
volatility
and
declines
in
global
financial
markets.
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict
leading
to
economic
sanctions
being
imposed
on
Russia
and
certain
of
its
citizens,
creating
impacts
on
Russian-related
stocks
and
debt
and
greater
volatility
in
global
markets.
These
are
recent
examples
of
global
events
which
may
have
a
negative
impact
on
the
values
of
certain
portfolio
holdings
or
the
fund’s
overall
performance.
Management
is
actively
monitoring
the
risks
and
financial
impacts
arising
from
these
events.
T.
ROWE
PRICE
Capital
Appreciation
Fund
REPORT
OF
INDEPENDENT
REGISTERED
PUBLIC
ACCOUNTING
FIRM
To
the
Board
of
Directors
and
Shareholders
of
T.
Rowe
Price
Capital
Appreciation
Fund,
Inc.
Opinion
on
the
Financial
Statements
We
have
audited
the
accompanying
statement
of
assets
and
liabilities,
including
the
portfolio
of
investments,
of
T.
Rowe
Price
Capital
Appreciation
Fund,
Inc.
(the
"Fund")
as
of
December
31,
2022,
the
related
statement
of
operations
for
the
year
ended
December
31,
2022,
the
statement
of
changes
in
net
assets
for
each
of
the
two
years
in
the
period
ended
December
31,
2022,
including
the
related
notes,
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
December
31,
2022
(collectively
referred
to
as
the
“financial
statements”).
In
our
opinion,
the
financial
statements
present
fairly,
in
all
material
respects,
the
financial
position
of
the
Fund
as
of
December
31,
2022,
the
results
of
its
operations
for
the
year
then
ended,
the
changes
in
its
net
assets
for
each
of
the
two
years
in
the
period
ended
December
31,
2022
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
December
31,
2022
in
conformity
with
accounting
principles
generally
accepted
in
the
United
States
of
America.
Basis
for
Opinion
These
financial
statements
are
the
responsibility
of
the
Fund’s
management.
Our
responsibility
is
to
express
an
opinion
on
the
Fund’s
financial
statements
based
on
our
audits.
We
are
a
public
accounting
firm
registered
with
the
Public
Company
Accounting
Oversight
Board
(United
States)
(PCAOB)
and
are
required
to
be
independent
with
respect
to
the
Fund
in
accordance
with
the
U.S.
federal
securities
laws
and
the
applicable
rules
and
regulations
of
the
Securities
and
Exchange
Commission
and
the
PCAOB.
We
conducted
our
audits
of
these
financial
statements
in
accordance
with
the
standards
of
the
PCAOB.
Those
standards
require
that
we
plan
and
perform
the
audit
to
obtain
reasonable
assurance
about
whether
the
financial
statements
are
free
of
material
misstatement,
whether
due
to
error
or
fraud.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Our
audits
included
performing
procedures
to
assess
the
risks
of
material
misstatement
of
the
financial
statements,
whether
due
to
error
or
fraud,
and
performing
procedures
that
respond
to
those
risks.
Such
procedures
included
examining,
on
a
test
basis,
evidence
regarding
the
amounts
and
disclosures
in
the
financial
statements.
Our
audits
also
included
evaluating
the
accounting
principles
used
and
significant
estimates
made
by
management,
as
well
as
evaluating
the
overall
presentation
of
the
financial
statements.
Our
procedures
included
confirmation
of
securities
owned
as
of
December
31,
2022
by
correspondence
with
the
custodian,
transfer
agent
and
brokers;
when
replies
were
not
received
from
brokers,
we
performed
other
auditing
procedures.
We
believe
that
our
audits
provide
a
reasonable
basis
for
our
opinion.
PricewaterhouseCoopers
LLP
Baltimore,
Maryland
February
16,
2023
We
have
served
as
the
auditor
of
one
or
more
investment
companies
in
the
T.
Rowe
Price
group
of
investment
companies
since
1973
REPORT
OF
INDEPENDENT
REGISTERED
PUBLIC
ACCOUNTING
FIRM
(continued)
T.
ROWE
PRICE
Capital
Appreciation
Fund
TAX
INFORMATION
(UNAUDITED)
FOR
THE
TAX
YEAR
ENDED 12/31/22
We
are
providing
this
information
as
required
by
the
Internal
Revenue
Code.
The
amounts
shown
may
differ
from
those
elsewhere
in
this
report
because
of
differences
between
tax
and
financial
reporting
requirements.
The
fund’s
distributions
to
shareholders
included:
$25,324,000 from
short-term
capital
gains
$3,601,930,000 from
long-term
capital
gains,
subject
to
a
long-term
capital
gains
tax
rate
of
not
greater
than
20%
For
taxable
non-corporate
shareholders,
$333,068,000 of
the
fund's
income
represents
qualified
dividend
income
subject
to
a
long-term
capital
gains
tax
rate
of
not
greater
than
20%.
For
corporate
shareholders,
$294,109,000
of
the
fund's
income
qualifies
for
the
dividends-received
deduction.
For
shareholders
subject
to
interest
expense
deduction
limitation
under
Section
163(j), $477,209,000 of
the
fund’s
income
qualifies
as
a
Section
163(j)
interest
dividend
and
can
be
treated
as
interest
income
for
purposes
of
Section
163(j),
subject
to
holding
period
requirements
and
other
limitations.
INFORMATION
ON
PROXY
VOTING
POLICIES,
PROCEDURES,
AND
RECORDS
A
description
of
the
policies
and
procedures
used
by
T.
Rowe
Price
funds
to
determine
how
to
vote
proxies
relating
to
portfolio
securities
is
available
in
each
fund’s
Statement
of
Additional
Information.
You
may
request
this
document
by
calling
1-800-225-5132
or
by
accessing
the
SEC’s
website,
sec.gov.
The
description
of
our
proxy
voting
policies
and
procedures
is
also
available
on
our
corporate
website.
To
access
it,
please
visit
the
following
Web
page:
https://www.troweprice.com/corporate/us/en/utility/policies.html
Scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Guidelines.”
Click
on
the
links
in
the
shaded
box.
Each
fund’s
most
recent
annual
proxy
voting
record
is
available
on
our
website
and
through
the
SEC’s
website.
To
access
it
through
T.
Rowe
Price,
visit
the
website
location
shown
above,
and
scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Records.”
Click
on
the
Proxy
Voting
Records
link
in
the
shaded
box.
T.
ROWE
PRICE
Capital
Appreciation
Fund
HOW
TO
OBTAIN
QUARTERLY
PORTFOLIO
HOLDINGS
The
fund
files
a
complete
schedule
of
portfolio
holdings
with
the
Securities
and
Exchange
Commission
(SEC)
for
the
first
and
third
quarters
of
each
fiscal
year
as
an
exhibit
to
its
reports
on
Form
N-PORT.
The
fund’s
reports
on
Form
N-PORT
are
available
electronically
on
the
SEC’s
website
(sec.gov).
In
addition,
most
T.
Rowe
Price
funds
disclose
their
first
and
third
fiscal
quarter-end
holdings
on
troweprice.com
.
T.
ROWE
PRICE
Capital
Appreciation
Fund
LIQUIDITY
RISK
MANAGEMENT
PROGRAM
In
accordance
with
Rule
22e-4
(Liquidity
Rule)
under
the
Investment
Company
Act
of
1940,
as
amended,
the
fund
has
established
a
liquidity
risk
management
program
(Liquidity
Program)
reasonably
designed
to
assess
and
manage
the
fund’s
liquidity
risk,
which
generally
represents
the
risk
that
the
fund
would
not
be
able
to
meet
redemption
requests
without
significant
dilution
of
remaining
investors’
interests
in
the
fund.
The
fund’s
Board
of
Directors
(Board)
has
appointed
the
fund’s
investment
adviser,
T.
Rowe
Price
Associates,
Inc.
(Adviser),
as
the
administrator
of
the
Liquidity
Program.
As
administrator,
the
Adviser
is
responsible
for
overseeing
the
day-to-day
operations
of
the
Liquidity
Program
and,
among
other
things,
is
responsible
for
assessing,
managing,
and
reviewing
with
the
Board
at
least
annually
the
liquidity
risk
of
each
T.
Rowe
Price
fund.
The
Adviser
has
delegated
oversight
of
the
Liquidity
Program
to
a
Liquidity
Risk
Committee
(LRC),
which
is
a
cross-functional
committee
composed
of
personnel
from
multiple
departments
within
the
Adviser.
The
Liquidity
Program’s
principal
objectives
include
supporting
the
T.
Rowe
Price
funds’
compliance
with
limits
on
investments
in
illiquid
assets
and
mitigating
the
risk
that
the
fund
will
be
unable
to
timely
meet
its
redemption
obligations.
The
Liquidity
Program
also
includes
a
number
of
elements
that
support
the
management
and
assessment
of
liquidity
risk,
including
an
annual
assessment
of
factors
that
influence
the
fund’s
liquidity
and
the
periodic
classification
and
reclassification
of
a
fund’s
investments
into
categories
that
reflect
the
LRC’s
assessment
of
their
relative
liquidity
under
current
market
conditions.
Under
the
Liquidity
Program,
every
investment
held
by
the
fund
is
classified
at
least
monthly
into
one
of
four
liquidity
categories
based
on
estimations
of
the
investment’s
ability
to
be
sold
during
designated
time
frames
in
current
market
conditions
without
significantly
changing
the
investment’s
market
value.
As
required
by
the
Liquidity
Rule,
at
a
meeting
held
on
July
25,
2022,
the
Board
was
presented
with
an
annual
assessment
prepared
by
the
LRC,
on
behalf
of
the
Adviser,
that
addressed
the
operation
of
the
Liquidity
Program
and
assessed
its
adequacy
and
effectiveness
of
implementation,
including
any
material
changes
to
the
Liquidity
Program
and
the
determination
of
each
fund’s
Highly
Liquid
Investment
Minimum
(HLIM).
The
annual
assessment
included
consideration
of
the
following
factors,
as
applicable:
the
fund’s
investment
strategy
and
liquidity
of
portfolio
investments
during
normal
and
reasonably
foreseeable
stressed
conditions,
including
whether
the
investment
strategy
is
appropriate
for
an
open-end
fund,
the
extent
to
which
the
strategy
involves
a
relatively
concentrated
portfolio
or
large
positions
in
particular
issuers,
and
the
use
of
borrowings
for
investment
purposes
and
derivatives;
short-term
and
long-term
cash
flow
projections
covering
both
normal
and
reasonably
foreseeable
stressed
conditions;
and
holdings
of
cash
and
cash
equivalents,
as
well
as
available
borrowing
arrangements.
T.
ROWE
PRICE
Capital
Appreciation
Fund
For
the
fund
and
other
T.
Rowe
Price
funds,
the
annual
assessment
incorporated
a
report
related
to
a
fund’s
holdings,
shareholder
and
portfolio
concentration,
any
borrowings
during
the
period,
cash
flow
projections,
and
other
relevant
data
for
the
period
of
April
1,
2021,
through
March
31,
2022.
The
report
described
the
methodology
for
classifying
a
fund’s
investments
(including
any
derivative
transactions)
into
one
of
four
liquidity
categories,
as
well
as
the
percentage
of
a
fund’s
investments
assigned
to
each
category.
It
also
explained
the
methodology
for
establishing
a
fund’s
HLIM
and
noted
that
the
LRC
reviews
the
HLIM
assigned
to
each
fund
no
less
frequently
than
annually.
During
the
period
covered
by
the
annual
assessment,
the
LRC
has
concluded,
and
reported
to
the
Board,
that
the
Liquidity
Program
continues
to
operate
adequately
and
effectively
and
is
reasonably
designed
to
assess
and
manage
the
fund’s
liquidity
risk.
LIQUIDITY
RISK
MANAGEMENT
PROGRAM
(continued)
T.
ROWE
PRICE
Capital
Appreciation
Fund
ABOUT
THE
FUND'S
DIRECTORS
AND
OFFICERS
Your
fund
is
overseen
by
a
Board
of
Directors
(Board)
that
meets
regularly
to
review
a
wide
variety
of
matters
affecting
or
potentially
affecting
the
fund,
including
performance,
investment
programs,
compliance
matters,
advisory
fees
and
expenses,
service
providers,
and
business
and
regulatory
affairs.
The
Board
elects
the
fund’s
officers,
who
are
listed
in
the
final
table.
The
directors
who
are
also
employees
or
officers
of
T.
Rowe
Price
are
considered
to
be
“interested”
directors
as
defined
in
Section
2(a)(19)
of
the
1940
Act
because
of
their
relationships
with
T.
Rowe
Price
and
its
affiliates.
The
business
address
of
each
director
and
officer
is
100
East
Pratt
Street,
Baltimore,
Maryland
21202.
The
Statement
of
Additional
Information
includes
additional
information
about
the
fund
directors
and
is
available
without
charge
by
calling
a
T.
Rowe
Price
representative
at
1-800-638-5660.
INDEPENDENT
DIRECTORS
(a)
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
Teresa
Bryce
Bazemore
(1959)
2018
[205]
President
and
Chief
Executive
Officer,
Federal
Home
Loan
Bank
of
San
Francisco
(2021
to
present);
President,
Radian
Guaranty
(2008
to
2017);
Chief
Executive
Officer,
Bazemore
Consulting
LLC
(2018
to
2021);
Director,
Chimera
Investment
Corporation
(2017
to
2021);
Director,
First
Industrial
Realty
Trust
(2020
to
present);
Director,
Federal
Home
Loan
Bank
of
Pittsburgh
(2017
to
2019)
Ronald
J.
Daniels
(b)
(1959)
2018
[0]
President,
The
Johns
Hopkins
University
and
Professor,
Political
Science
Department,
The
Johns
Hopkins
University
(2009
to
present);
Director,
Lyndhurst
Holdings
(2015
to
present);
Director,
BridgeBio
Pharma,
Inc.
(2020
to
present)
Bruce
W.
Duncan
(1951)
2013
[205]
President,
Chief
Executive
Officer,
and
Director,
CyrusOne,
Inc.
(2020
to
2021);
Chief
Executive
Officer
and
Director
(2009
to
2016),
Chair
of
the
Board
(2016
to
2020),
and
President
(2009
to
2016),
First
Industrial
Realty
Trust,
owner
and
operator
of
industrial
properties;
Chair
of
the
Board
(2005
to
2016)
and
Director
(1999
to
2016),
Starwood
Hotels
&
Resorts,
a
hotel
and
leisure
company;
Member,
Investment
Company
Institute
Board
of
Governors
(2017
to
2019);
Member,
Independent
Directors
Council
Governing
Board
(2017
to
2019);
Senior
Advisor,
KKR
(2018
to
present);
Director,
Boston
Properties
(2016
to
present);
Director,
Marriott
International,
Inc.
(2016
to
2020)
Robert
J.
Gerrard,
Jr.
(1952)
2012
[205]
Advisory
Board
Member,
Pipeline
Crisis/Winning
Strategies,
a
collaborative
working
to
improve
opportunities
for
young
African
Americans
(1997
to
2016);
Chair
of
the
Board,
all
funds
(July
2018
to
present)
T.
ROWE
PRICE
Capital
Appreciation
Fund
INTERESTED DIRECTORS
(a)
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
Paul
F.
McBride
(1956)
2013
[205]
Advisory
Board
Member,
Vizzia
Technologies
(2015
to
present);
Board
Member,
Dunbar
Armored
(2012
to
2018)
Kellye
L.
Walker
(c)
(1966)
2021
[205]
Executive
Vice
President
and
Chief
Legal
Officer,
Eastman
Chemical
Company
(April
2020
to
present);
Executive
Vice
President
and
Chief
Legal
Officer,
Huntington
Ingalls
Industries,
Inc.
(January
2015
to
March
2020);
Director,
Lincoln
Electric
Company
(October
2020
to
present)
(a)
All
information
about
the
independent
directors
was
current
as
of
December
31,
2021,
unless
otherwise
indicated,
except
for
the
number
of
portfolios
overseen,
which
is
current
as
of
the
date
of
this
report.
(b)
Effective
April
27,
2022,
Mr.
Daniels
resigned
from
his
role
as
an
independent
director
of
the
Price
Funds.
(c)
Effective
November
8,
2021,
Ms.
Walker
was
appointed
as
an
independent
director
of
the
Price
Funds.
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
David
Oestreicher
(1967)
2018
[205]
Director,
Vice
President,
and
Secretary,
T.
Rowe
Price,
T.
Rowe
Price
Investment
Services,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
and
T.
Rowe
Price
Services,
Inc.;
Director
and
Secretary,
T.
Rowe
Price
Investment
Management,
Inc.
(Price
Investment
Management);
Vice
President
and
Secretary,
T.
Rowe
Price
International
(Price
International);
Vice
President,
T.
Rowe
Price
Hong
Kong
(Price
Hong
Kong),
T. Rowe
Price
Japan
(Price
Japan),
and
T.
Rowe
Price
Singapore
(Price
Singapore);
General
Counsel,
Vice
President,
and
Secretary,
T.
Rowe
Price
Group,
Inc.;
Chair
of
the
Board,
Chief
Executive
Officer,
President,
and
Secretary,
T.
Rowe
Price
Trust
Company;
Principal
Executive
Officer
and
Executive
Vice
President,
all
funds
Robert
W.
Sharps,
CFA,
CPA
(b)
(1971)
2017
[0]
Director
and
Vice
President,
T.
Rowe
Price;
Director,
Price
Investment
Management;
Chief
Executive
Officer
and
President,
T.
Rowe
Price
Group,
Inc.;
Vice
President,
T.
Rowe
Price
Trust
Company
INDEPENDENT
DIRECTORS
(a)
(CONTINUED)
T.
ROWE
PRICE
Capital
Appreciation
Fund
OFFICERS
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
Eric
L.
Veiel,
CFA
(1972)
2022
[205]
Director
and
Vice
President,
T.
Rowe
Price;
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
(a)
All
information
about
the
interested
directors
was
current
as
of
January
1,
2022,
unless
otherwise
indicated,
except
for
the
number
of
portfolios
overseen,
which
is
current
as
of
the
date
of
this
report.
(b)
Effective
February
3,
2022,
Mr.
Sharps
resigned
from
his
role
as
an
interested
director
of
the
Price
Funds.
Name
(Year
of
Birth)
Position
Held
With
Capital
Appreciation
Fund
Principal
Occupation(s)
Armando
(Dino)
Capasso
(1974)
Chief
Compliance
Officer
Chief
Compliance
Officer
and
Vice
President,
T.
Rowe
Price
and
Price
Investment
Management;
Vice
President,
T.
Rowe
Price
Group,
Inc.;
formerly,
Chief
Compliance
Officer,
PGIM
Investments
LLC
and
AST
Investment
Services,
Inc.
(ASTIS)
(to
2022);
Chief
Compliance
Officer,
PGIM
Retail
Funds
complex
and
Prudential
Insurance
Funds
(to
2022);
Vice
President
and
Deputy
Chief
Compliance
Officer,
PGIM
Investments
LLC
and
ASTIS
(to
2019);
Senior
Vice
President
and
Senior
Counsel,
Pacific
Investment
Management
Company
LLC
(to
2017)
Paul
Cho
(1986)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Alan
S.
Dupski,
CPA
(1982)
Principal
Financial
Officer,
Vice
President,
and
Treasurer
Vice
President,
Price
Investment
Management,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Donald
J.
Easley,
CFA
(1971)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Matthew
Frustaci
(1990)
Vice
President
Vice
President,
Price
Investment
Management;
formerly
student,
The
Wharton
School,
University
of
Pennsylvania
(to
2020);
summer
intern,
T.
Rowe
Price
(2019);
Finance
and
Strategy
Manager,
CircleCI
(to
2018)
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
INTERESTED DIRECTORS
(a)
(CONTINUED)
T.
ROWE
PRICE
Capital
Appreciation
Fund
Name
(Year
of
Birth)
Position
Held
With
Capital
Appreciation
Fund
Principal
Occupation(s)
David
R.
Giroux,
CFA
(1975)
President
Vice
President,
Price
Investment
Management,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Gary
J.
Greb
(1961)
Vice
President
Vice
President,
Price
Investment
Management,
T.
Rowe
Price,
Price
International,
and
T.
Rowe
Price
Trust
Company
Cheryl
Hampton,
CPA
(1969)
Vice
President
Vice
President,
T.
Rowe
Price;
formerly,
Tax
Director,
Invesco
Ltd.
(to
2021);
Vice
President,
Oppenheimer
Funds,
Inc.
(to
2019)
Benjamin
Kersse,
CPA
(1989)
Vice
President
Vice
President,
T.
Rowe
Price
Steven
D.
Krichbaum
(1977)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Paul
J.
Krug,
CPA
(1964)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Kevin
Patrick
Loome,
CFA
(1967)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Fran
M.
Pollack-Matz
(1961)
Vice
President
and
Secretary
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
T.
Rowe
Price
Investment
Services,
Inc.,
and
T.
Rowe
Price
Services,
Inc.
Vivek
Rajeswaran
(1985)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Shannon
H.
Rauser
(1987)
Assistant
Secretary
Assistant
Vice
President,
T.
Rowe
Price
Nathan
Segal
(1985)
Vice
President
Vice
President,
Price
Investment
Management;
formerly,
student,
The
Graduate
School
of
Business,
Stanford
University
(to
2020);
summer
intern,
T.
Rowe
Price
(2019);
Charles
P.
Bonini
Fellow,
Eli
Lilly
(to
2018)
Farris
G.
Shuggi
(1984)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Mike
Signore
(1987)
Vice
President
Vice
President,
Price
Investment
Management
Brian
Solomon,
CFA
(1986)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Matthew
Stevenson
(1991)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.;
formerly
student,
Columbia
Business
School
(to
2019)
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Name
(Year
of
Birth)
Position
Held
With
Capital
Appreciation
Fund
Principal
Occupation(s)
Chen
Tian
(1993)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Megan
Warren
(1968)
Vice
President
OFAC
Sanctions
Compliance
Officer
and
Vice
President,
Price
Investment
Management;
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
T.
Rowe
Price
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Tamara
P.
Wiggs
(1979)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Jon
Davis
Wood,
CFA
(1979)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Ashley
R.
Woodruff,
CFA
(1979)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
T.
Rowe
Price
Investment
Services,
Inc.
|
100
East
Pratt
Street
|
Baltimore,
MD
21202-1009
You
have
many
investment
goals.
Explore
products
and
services
that
can
help
you
achieve
them.
Whether
you
want
to
put
away
more
money
for
retirement,
for
a
child’s
education,
or
for
other
priorities,
we
have
solutions
for
you.
See
how
we
can
help
you
accomplish
the
investment
goals
that
are
important
to
you.
RETIREMENT
IRAs:
Traditional,
Roth,
Rollover/Transfer,
or
Brokerage
Small
Business
Plans
help
minimize
taxes,
maximize
savings
T.
Rowe
Price
®
ActivePlus
Portfolios
1
for
online
investing
powered
by
experts
GENERAL
INVESTING
Individual
or
Joint
Tenant
Brokerage
2
offers
access
to
stocks,
ETFs,
bonds,
and
more
Gifts
and
transfers
to
a
child
(UGMA/UTMAs)
Trust
Transfer
on
Death
COLLEGE
SAVINGS
T.
Rowe
Price-managed
529
plans
offer
tax-
advantaged
solutions
for
families
saving
money
for
college
tuition
and
education-
related
expenses
Visit
troweprice.com/broadrange
Call
1-800-225-5132
to
request
a
prospectus
or
summary
prospectus;
each
includes
investment
objectives,
risks,
fees,
expenses,
and
other
information
that
you
should
read
and
consider
carefully
before
investing.
All
mutual
funds
are
subject
to
market
risk,
including
possible
loss
of
principal.
Investing
internationally
involves
special
risks
including
economic
and
political
uncertainty
and
currency
fluctuation.
1
The
T.
Rowe
Price
®
ActivePlus
Portfolios
is
a
discretionary
investment
management
program
provided
by
T.
Rowe
Price
Advisory
Services,
Inc.,
a
registered
investment
adviser
under
the
Investment
Advisers
Act
of
1940.
Brokerage
services
are
provided
by
T.
Rowe
Price
Investment
Services,
Inc.,
member
FINRA/SIPC.
Brokerage
accounts
are
carried
by
Pershing
LLC,
a
BNY
Mellon
Company,
member
NYSE/FINRA/SIPC.
T.
Rowe
Price
Advisory
Services,
Inc.,
and
T.
Rowe
Price
Investment
Services,
Inc.,
are
affiliated
companies.
2
Brokerage
services
are
provided
by
T.
Rowe
Price
Investment
Services,
Inc.,
member
FINRA/SIPC.
Brokerage
accounts
are
carried
by
Pershing
LLC,
a
BNY
Mellon
Company,
member
NYSE/FINRA/SIPC.
202302-2582057
F72-050
2/23
Item 1. (b) Notice pursuant to Rule 30e-3.
Not applicable.
Item 2. Code of Ethics.
The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR, applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR. No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.
Item 3. Audit Committee Financial Expert.
The registrant’s Board of Directors has determined that Ms. Teresa Bryce Bazemore qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR. Ms. Bazemore is considered independent for purposes of Item 3 of Form N-CSR.
Item 4. Principal Accountant Fees and Services.
(a) – (d) Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant’s principal accountant were as follows:
| | | | | | | | | | |
| | | | 2022 | | | 2021 | |
| Audit Fees | | $ | 41,909 | | | $ | 40,759 | |
| Audit-Related Fees | | | - | | | | - | |
| Tax Fees | | | - | | | | 5,742 | |
| All Other Fees | | | - | | | | - | |
Audit fees include amounts related to the audit of the registrant’s annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant’s financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant’s pro-rata share of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant’s Board of Directors/Trustees.
(e)(1) The registrant’s audit committee has adopted a policy whereby audit and non-audit services performed by the registrant’s principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approval in advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approval may be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approval for audit or non-audit services requiring fees of a de minimis amount is not permitted.
(2) No services included in (b) – (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
(f) Less than 50 percent of the hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.
(g) The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant’s principal accountant for non-audit services rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $2,037,000 and $3,732,000, respectively.
(h) All non-audit services rendered in (g) above were pre-approved by the registrant’s audit committee. Accordingly, these services were considered by the registrant’s audit committee in maintaining the principal accountant’s independence.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) Not applicable. The complete schedule of investments is included in Item 1 of this Form N-CSR.
(b) Not applicable.
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10. Submission of Matters to a Vote of Security Holders.
There has been no change to the procedures by which shareholders may recommend nominees to the registrant’s board of directors.
Item 11. Controls and Procedures.
(a) The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSR was recorded, processed, summarized, and reported timely.
(b) The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 13. Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
T. Rowe Price Capital Appreciation Fund, Inc.
| | |
By | | /s/ David Oestreicher |
| | David Oestreicher |
| | Principal Executive Officer |
| |
Date | | February 16, 2023 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| | |
| |
By | | /s/ David Oestreicher |
| | David Oestreicher |
| | Principal Executive Officer |
| |
Date | | February 16, 2023 |
| |
By | | /s/ Alan S. Dupski |
| | Alan S. Dupski |
| | Principal Financial Officer |
| |
Date | | February 16, 2023 |